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In the literature, depression (especially major depressive disorder [MDD]) and posttraumatic 
disorder (PTSD) have been known to significantly increase individuals’ risk for dementia. 
Dementia affects 5 to 7 percent of the population across the world. Compared to the general U.S. 
population, the Veteran population experiences significantly greater risk factors associated with 
dementia and other forms of cognitive impairment. As this population continues to age and 
diversify in the upcoming years, risk factors specific to their circumstances must be examined. 
Importantly, similar patterns of health disparities that persist in the general population among 
men, women, and different racial groups, also exist among the Veteran population. Thus, despite 
minimization of financial barriers in VA healthcare systems, there are still certain groups with a 
greater likelihood of developing certain diseases. The aim of this study was to examine MDD 
and PTSD as predictors of dementia and other forms of cognitive impairment (cognitive 
impairment not demented [CIND]) among Veterans aged ≥ 60 years (N = 4,800) with sex and 
race analyzed as potential moderators. Hierarchical and backward logistic regression analyses 
were conducted to determine significant predictors of dementia/CIND. When controlling for the 
other, a history of MDD and PTSD both were associated with almost double the risk for 
developing dementia/CIND. Moreover, when a history of MDD was indicated, Black Veterans’ 
risk of dementia/CIND increased almost twofold. Additional findings and implications are also 
discussed.  





 Thank you to my wonderful committee members for everything they have done to make 
this happen. I want to especially thank my advisor, mentor, and friend, Dr. Karen Multon, for the 
encouragement, compassion, and motivation she has given me through this process. You have 
shown me unconditional support, even with my high energy levels that can be tiring at times. 
Thank you to Dr. Mary Oehlert, who opened her arms to me and spent endless “anxious” hours 
helping me work with the VA data. Thank you to Dr. Tom McDonald, whose eyesight may be 
worse now after the amount of time he spent looking at the computer screen when helping with 
my data analyses efforts. Also, thank you to Dr. Tom Krieshok and Dr. Changming Duan for 
your continued support, encouragement, and contribution to my personal and professional 
growth as a doctoral candidate.  
Thank you to Dr. Scott Sumerall, my clinical supervisor, for making this project possible 
and getting it developed. You have been incredibly understanding of how demanding this 
process can be and I will always appreciate that. I also want to thank Kim Bruns, my GRA 
supervisor, who is one of the most encouraging and empathetic people I know. Your support 
during some of my hardest days will not be forgotten.  
Thank you to my little sister, who always stood by my side no matter the circumstance. 
To Mary, who has become part of my family and could always be depended upon for support 
and to listen to my endless worries. Thank you to all my extended family members and friends 
who were continually there for me throughout this entire process.  
Of course, thank you to my kittens, Dylan and Diego, for giving me so much love during 
endless hours of writing. Your furry warmth and soft cuddles made every minute of writing more 
bearable. Thank you to my partner, Eric, who somehow managed to survive my dissertation 
v 
 
process. Congratulations—we made it! I cannot imagine doing this without your complete 
dedication to my professional success.  
Finally, I want to thank the two people I could not have done this without: my parents. 
Your hard work, determination, and unwavering confidence in me has made me the person I am 
today. You have always believed in me, and this is what motivates me to continue working 
towards my passion each and every single day. You two are my rock, my strength, and 
everything I hope to become.   
vi 
 
TABLE OF CONTENTS 
CHAPTER 1 ................................................................................................................................... 9 
Abstract ..................................................................................................................................................... 9 
Predictors of Dementia for Veterans with and without Preexisting Depression and PTSD ................... 10 
Depression ............................................................................................................................................... 13 
Posttraumatic Stress Disorder (PTSD) .................................................................................................... 14 
Relationship between Dementia, Depression, and PTSD ....................................................................... 16 
Depression as a Risk Factor for Dementia .............................................................................................. 18 
PTSD as a Risk Factor for Dementia: Recent Discoveries ..................................................................... 19 
Diversification of the Population ............................................................................................................ 19 
Sex Disparities in Diagnoses ................................................................................................................... 20 
Racial Disparities in Diagnoses .............................................................................................................. 22 
Explanations for Disparities .................................................................................................................... 25 
Health Care Providers’ Roles .............................................................................................................. 26 
Neuropsychology and Universalism ................................................................................................... 27 
Differences in Coping Mechanisms .................................................................................................... 28 
The Public Health Critical Race (PHCR) Praxis................................................................................. 29 
Veteran Population .................................................................................................................................. 30 
Summary and Conclusions ...................................................................................................................... 30 
References ............................................................................................................................................... 33 
CHAPTER 2 ................................................................................................................................. 47 
Abstract ................................................................................................................................................... 47 
History of MDD and PTSD as Risk Factors for Dementia and Cognitive Impairment Not Demented 
(CIND) among U.S. Veterans: A Retrospective Cohort Study ............................................................... 48 
Cognitive Impairment Not Demented (CIND) ....................................................................................... 49 
Chronic Stress: The Link between MDD and PTSD .............................................................................. 50 
Changes in the Population ....................................................................................................................... 51 
Prevalence Rates ..................................................................................................................................... 52 
Dementia and CIND ........................................................................................................................... 52 
Depression and PTSD ......................................................................................................................... 54 
Role of Sex and Race .............................................................................................................................. 57 
Patients’ Demographic Characteristics and Providers’ Impressions ....................................................... 58 
Objectives and Rationale of the Present Study ....................................................................................... 60 
vii 
 
Methods ................................................................................................................................................... 62 
Inclusion and Exclusion Criteria ......................................................................................................... 63 
A Priori Statistical Power Analysis ..................................................................................................... 66 
Sampling Procedures .......................................................................................................................... 68 
Participants .......................................................................................................................................... 69 
Data Analysis ...................................................................................................................................... 71 
Results ..................................................................................................................................................... 78 
Demographic Characteristics .............................................................................................................. 78 
Subgroup Characteristics .................................................................................................................... 81 
Relationships among Predictor and Outcome Variables ..................................................................... 82 
Logistic Regression Analysis .............................................................................................................. 85 
Model Validity and Discrimination Power ......................................................................................... 94 
Discussion ............................................................................................................................................... 96 
Prevalence Rates ................................................................................................................................. 98 
MDD and PTSD ................................................................................................................................ 100 
Sex and Race ..................................................................................................................................... 101 
Findings Unique to Veterans of Age ≥ 60 Years .............................................................................. 101 
Limitations ............................................................................................................................................ 103 
Implications ........................................................................................................................................... 105 
Conclusion ............................................................................................................................................ 108 
References ............................................................................................................................................. 110 
Table 1. Groups of Veterans by Sex, Race, and History of Psychiatric Disorder ................................. 129 
Table 2. Characteristics of Veterans with and without Dementia/CIND .............................................. 130 
Table 3. Characteristics of Veterans in Each of the 12 Subgroups with and without          
Dementia/CIND  ................................................................................................................................... 131 
Table 4. Frequency or Mean Values for Predictor Variables of Dementia/CIND included in Logistic 
Regression Analyses ............................................................................................................................. 132 
Table 5. Intercorrelations for Dementia/CIND and Predictor Variables............................................... 133 
Table 6. Collinearity Diagnostics for Predictor Variables of Dementia/CIND .................................... 134 
Table 7. Model 1: Logistic Regression Predicting Dementia/CIND at Age > 55 (including Sex and 
Race) ..................................................................................................................................................... 135 
Table 8. Model 2: Logistic Regression Predicting Dementia/CIND at Age > 55 (including Sex) ....... 136 
Table 9. Model 3: Logistic Regression Predicting Dementia/CIND at Age > 55 (including Race) ..... 137 
Table 10. Observed and Predicted Frequencies for Dementia/CIND by Logistic Regression         
Models ................................................................................................................................................... 138 
Figure 1. Flowchart of Study Participant Selection with Inclusion/Exclusion Criteria. ....................... 139 
Figure 2. Number of Dementia/CIND Cases (diagnosed at age > 55) per Subgroup, divided by    
Cohorts 1, 2, and 3. ............................................................................................................................... 140 
viii 
 
Figure 3. Comparison of Risk of Dementia/CIND (mean predicted probabilities) based on MDD/PTSD 
History by Logistic Regression Models Adjusted and Unadjusted for Current Age ............................ 141 
Figure 4. Risk of Dementia/CIND based on Sex and Race .................................................................. 142 
Figure 5. Receiver Operating Characteristic (ROC) Curve for Risk of Dementia/CIND (diagnosed at 
age > 55) based on Logistic Regression Models 1c, 2a, and 3c .............................................................. 143 
Appendix A. ICD-9 Dementia and Cognitive Impairment Not Demented (CIND) Codes and 
Descriptions .......................................................................................................................................... 144 
Appendix B. ICD-9 Major Depressive Disorder (MDD) and Posttraumatic Stress Disorder (PTSD) 





Dementia is prevalent among 5 to 7 percent of the population worldwide, and 3.4 million persons 
aged ≥ 71 in the U.S. A history of depression and/or PTSD has been associated with a greater 
risk of dementia, yet the relationship between these conditions with dementia remains unclear. 
Depression is the most notable contributor to the worldwide burden of disease, and PTSD has 
been found to be more common in the U.S. than other countries, especially considering recent 
conflicts in which U.S. Veterans have been involved, such as Operation Iraqi Freedom (OIF) and 
Operation Enduring Freedom (OEF). The U.S. Veteran population has been recognized for being 
at a greater risk for depression/PTSD and cognitive difficulties, making them an important group 
to consider for research. Importantly, as the Veteran population rapidly diversifies, health care 
providers must develop and maintain cultural competency across areas of assessment, diagnosis, 
and treatment. This is particularly important given that substantial sex and racial health 
disparities have endured in the U.S. for several decades. Due to the complex relationship 
between depression/PTSD and dementia, as well as the increased risk among Veterans, 
additional research is needed to understand psychiatric risk factors of dementia and how 
Veterans’ demographic characteristics may influence this risk.   






Predictors of Dementia for Veterans with and without Preexisting Depression and PTSD:  
A Review 
The worldwide economic burden of dementia in 2010 was approximately $604 billion, 
which is one percent of the worldwide gross domestic product (GDP; World Health 
Organization, 2015). There are approximately 47.5 million people worldwide living with 
dementia, and 7.7 million others are diagnosed with dementia each year. The World Alzheimer 
Report 2010, published by Alzheimer's Disease International (2010), demonstrated how 
significant the impact of dementia is: “If dementia care were a country, it would be the world’s 
18th largest economy (ranking between Turkey and Indonesia)….If dementia were a company, it 
would be the world’s largest by annual revenue, exceeding Wal-Mart ($414 billion) and Exxon 
Mobil ($311 billion)” (p. 5). In the United States (U.S.), the economic cost of dementia was 
estimated to be $226 billion in 2015, and expected to rise as high as $1.1 trillion by 2050 
(Alzheimer's Association, 2015).  
Dementia is a disorder characterized by cognitive and behavioral symptoms that 
“interfere with the ability to function at work or at usual activities; represent a decline from 
previous levels of functioning and performing; are not explained by delirium or major 
psychiatric disorder; and, cognitive impairment is detected and diagnosed…” (National Institute 
on Aging’s Alzheimer’s Associated Workgroups; McKhann et al., 2011, p. 265). Cognitive 
impairment must be detected through a clinical interview about the patient’s history and 
objective cognitive assessment. Examples of cognitive impairment include the following 
(McKhann et al., 2011, p. 265): changes in behavior/personality (e.g., uncharacteristic mood 
fluctuations); impaired language and/or visuospatial abilities, and; impaired reasoning and 
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handling of complex tasks, poor judgement, and impaired ability to acquire and remember new 
information.  
The prevalence rate of dementia increases with age, with the overall U.S. national rate 
being 13.93 percent, with higher rates among women (15.74 percent) compared to men (11.4 
percent; Plassman et al., 2007).  In fact, approximately two thirds of Americans diagnosed with 
Alzheimer’s disease (the most common form of dementia) are women (Alzheimer's Association, 
2015). Prevalence rates by age groups are 4.97 percent for individuals aged 71 to 79 years, 24.19 
percent for individuals aged 80 to 89 years, and 37.36 percent for individuals aged 90 years or 
older (Plassman et al., 2007). Dementia is the six leading cause of mortality in the U.S. 
(Alzheimer's Association, 2015).  
Although there is no cure for dementia, scientists have developed treatments that delay 
cognitive decline and help individuals and their caretakers manage symptoms (Farlow, Miller, & 
Pejovic, 2008). Treatment options include pharmacological approaches, cognitive training, and 
preventative efforts (e.g., lifestyle changes, exercise, healthy eating, and early and efficient 
diagnosis). Many researchers have also identified potential risk factors of dementia (Byers & 
Yaffe, 2011; Chen, Lin, & Chen, 2009; Reddy & Beal, 2008). The APOE gene, particularly the 
variant APOE4, is the strongest genetic risk factor for dementia (Chen et al., 2009). The 
literature shows that beta-amyloid is a major component of the neuritic plaques or amyloid 
deposits found in the brain of persons diagnosed with dementia, particularly Alzheimer’s disease 
(Reddy & Beal, 2008). Notably, a risk factor that is consistent across all ethnic groups is age; as 
individuals get older, their risk for dementia increases (Chen et al., 2009). Byers and Yaffe 
(2011) indicated that persons with a history of depression have double the risk of getting 
dementia compared to those without a history of depression. Additional identified risk factors 
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include level of physical activity, education, body mass index, alcohol and drug use, smoking, 
and comorbidity with various diseases (e.g., HIV, hepatitis C virus, traumatic brain injury, and 
hypertension).  
It is important to note that researchers have identified U.S. Veterans as having an 
increased risk of developing dementia (Lohr et al., 2015; Sibener et al., 2014). They have 
mentioned several reasons why Veterans may be at greater risk, with the demographic 
characteristics of the group being a significant factor. On average, Veterans are older than non-
Veterans and the Veteran population consists of a higher proportion of Black individuals than the 
overall U.S. population (Sibener et al., 2014). As people get older, their risk of dementia 
increases. Further, Black persons are at greater risk for dementia compared to other racial groups 
(Plassman et al., 2007). Specifically, the incidence of Alzheimer’s disease among Black 
individuals is double that of their White counterparts (Sibener et al., 2014). Moreover, the 
incidence of traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) is increasing 
among the Veteran population, and researchers identified both as risk factors of dementia 
(Shively & Perl, 2012). Veterans are also at a higher risk for depression, as this condition shares 
many symptoms with PTSD, and depression has been identified by scholars as a major risk for 
dementia (Barnes et al., 2012; Byers & Yaffe, 2011; Sibener et al., 2014).  
Despite identified risk factors, there are no definite indicators for dementia. In fact, there 
are some individuals who have risk factors that are strongly associated with dementia, yet they 
never exhibit symptoms (Bennett et al., 2006; Tomlinson, 1968). For instance, Bennett et al. 
(2006) found Alzheimer’s disease pathology (e.g., neuritic plaques) in the brains of a large 
number of persons without dementia or mild cognitive impairment. This suggests that even the 
risk factors with the most scientific evidence do not guarantee the later development or absence 
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of dementia. Hence, there exists a great need for additional research involving the examination of 
the risk factors of dementia. In addition, given the increased risk U.S. Veterans have, it is 
important to investigate factors unique to this population (e.g., PTSD, depression, TBI, 
demographic characteristics, and more) that act as significant risks.  
Depression 
Depression is characterized by a change in mood (e.g., sadness, loneliness, apathy), 
negative self-concept (e.g., self-blame), regressive and self-punitive wishes, vegetative changes, 
and different activity levels (Beck, 2009). Numerous environmental and biological factors may 
increase people’s risk for depression, including the following: familial environment and adverse 
experiences in childhood, social/cultural environment and people’s roles within their 
environment (e.g., poor social support), adverse life events, genetic and hereditary factors, co-
morbidity with other conditions (e.g., sleep disorders and cognitive impairment), and more 
(Piccinelli & Wilkinson, 2000). Importantly, risk factors for depression among older adults aged 
≥ 50 years are slightly different than the risks for the general population, and include 
bereavement, sleep disturbance, disability, cognitive decline, prior depression, and female gender 
(Cole & Dendukuri, 2003).  
Depression is the most noteworthy contributor to the global burden of disease, and it is 
the most frequently encountered women’s mental health problem (WHO; World Health 
Organization, 2002). The lifetime prevalence rates of depression among women are significantly 
higher than the rates for men, and this remains consistent across racial groups; the approximate 
lifetime prevalence of MDD is 21.3 percentage for women, and 12.7 percentage for men 
(Kessler, 2003; Mielke, Vemuri, & Rocca, 2014; Piccinelli & Wilkinson, 2000; WHO, 2002). 
There are some inconsistent findings on depression prevalence rates among older men and 
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women, yet more recently, researchers determined that women continue to be at a greater risk for 
depression even later in life (Barefoot, Mortensen, Helms, Avlund, & Schroll, 2001; Djernes, 
2006; Hybels, Blazer, & Pieper, 2001; Meeks, Vahia, Lavretsky, Kulkarni, & Jeste, 2011).  
Treatment options for depression have advanced over the decades and individuals now 
have several treatment choices, such as psychopharmacology, psychotherapy, and 
electroconvulsive therapy (ECT; Beck, 2009). Due to the extant prevalence of depression 
worldwide, researchers continue to investigate additional treatment options, and future directions 
include transcranial magnetic stimulation and pharmacogenomics (Beck, 2009; Hamilton, 2015). 
Transcranial magnetic stimulation, also known as repetitive transcranial magnetic stimulation 
(rTMS), is a variation of ECT that stimulates the brain non-convulsively and is associated with 
fewer side effects compared to ECTs (Vallejo-Torres et al., 2015). Psychiatric 
pharmacogenomics is the study of how peoples’ genetics influence how they respond to certain 
medications (Hamilton, 2015) and it has the potential to make a profound impact on the 
effectiveness of antidepressants for the larger population. Recent controversial research findings 
demonstrate that benefits of antidepressants compared with placebos are nonexistent to minimal 
for patients with mild to moderate depression (Fournier et al., 2010), and pharmacogenomics 
could potentially help scientists discover types of antidepressants that are more effective for 
certain individuals compared to others. Nonetheless, rTMS and pharmacogenomics still require 
further vigorous investigation prior to being widely accepted and employed as common 
treatments for depression (Vallejo-Torres et al., 2015).  
Posttraumatic Stress Disorder (PTSD) 
The International Classification of Diseases, Ninth Revision (ICD-9; Centers for Disease 
Control and Prevention, 2011) outlines the criteria for posttraumatic stress disorder (PTSD) as a 
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reaction to experiencing or being exposed to a traumatic experience which results in impaired 
functioning manifesting in the following: re-experiencing the event (e.g., nightmares, 
recollections, and flashbacks); thoughts, feelings, and activities of traumatic circumstances; 
changes in affective functioning (e.g., unable to experience certain emotions), and; irritability, 
hypervigilance, insomnia, etc. Numerous risk factors for PTSD have been identified, with 
women consistently being at a higher risk compared to their male counterparts (Breslau, 2009). 
Women have greater odds of developing PTSD following a traumatic incident compared to men. 
Moreover, women in the military have a higher risk of experiencing traumatic incidents 
compared to women in the general community, thus making them more likely to develop PTSD 
(Breslau, 2009; Haskell et al., 2010). The female Veteran population is rising in the U.S., and 
this has many significant implications for health care providers who work with this particular 
group (Breslau, 2009; Dobie et al., 2004).  
Sandica and Pop (2014) found that, similar to depression, smaller hippocampal volume in 
the brain may be associated with more susceptibility to PTSD. Additional risk factors include 
prior affective, anxiety, substance use, and/or personality disorders (Sandica & Pop, 2014). The 
existing options for PTSD treatment include evidence-based interventions, with Cognitive 
Behavioral Therapies being the most common (e.g., Cognitive Processing Therapy, Prolonged 
Exposure, etc.; Gradus, 2007). Psychopharmacology and eye movement desensitization and 
reprocessing (EMDR) are also common approaches for PTSD treatment.  
The U.S. population has higher prevalence rates of PTSD compared to other countries, 
with higher rates of women diagnosed with PTSD than men in the general public (Breslau, 
2009). However, researchers are expecting PTSD rates for women to increase even more as the 
population of female U.S. Veterans also grows. In addition, Seal and colleagues (2009) found 
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that active duty Veterans who are less than 25 years old are at a higher risk for PTSD compared 
to active duty Veterans who are older than 40 years of age.  
Racial differences in PTSD rates are also significant, with Black persons consistently 
having greater risks compared to other racial groups (Asnaani, Richey, Dimaite, Hinton, & 
Hofmann, 2010; Himle, Baser, Taylor, Campbell, & Jackson, 2009; Roberts, Gilman, Breslau, 
Breslau, & Koenen, 2011). Lifetime prevalence rates of PTSD are highest among Black 
individuals when compared to White, Hispanic, and Asian populations (Roberts et al., 2011). 
However, Black individuals, and all other minority groups, are less likely to seek PTSD 
treatment compared to their White counterparts (Roberts et al., 2011).  
Relationship between Dementia, Depression, and PTSD 
The existing knowledgebase on the relationship between dementia, depression, and PTSD 
remains inconclusive, and many researchers present varying conclusions regarding whether one 
can cause the other, act as a risk factor, etc. Depression has been examined by countless 
researchers for decades to better understand its association with dementia, and many hypotheses 
have been offered (Butters et al., 2008; Byers & Yaffe, 2011; Jorm, 2001; Korczyn & Halperin, 
2009). Depression can be a possible reaction to dementia, or a prodrome (i.e., an early symptom) 
of dementia (Byers & Yaffe, 2011). Depression can also be a reaction of people experiencing 
decline in their memory (Korczyn & Halperin, 2009). One finding, however, that the majority of 
researchers seem to agree on is that a history of depression increases the risk of dementia 
(Korczyn & Halperin, 2009), particularly for older adults (Chodosh, Kado, Seeman, & 
Karlamangla, 2007).  
It can be difficult for even the most skilled clinicians to distinguish between dementia and 
depression due to similarities in their features, particularly the presentations of cognitive 
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symptoms (Casey, 2012). Hence, depression and dementia are commonly misdiagnosed as the 
other, especially in older adults (Casey, 2012). Older adults with depression and/or dementia 
both exhibit forgetfulness, lack of concentration, reasoning, and other cognitive impairment. 
Nebes and colleagues (2000) found that decreased working memory and processing speed 
mediated cognitive impairment in geriatric depression. Importantly, people with depression are 
usually able to recall memories if they try, whereas those with dementia typically try to conceal 
the fact that they are unable to recall anything. Reasoning and memory are impaired in both 
dementia and depression, and this cannot be treated for in dementia. In depression, poor 
concentration and other cognitive impairments are reversible with treatment or when the 
depression is in remission. Further, Byers and Yaffe (2011) identified a condition called 
pseudodementia, which occurs when depression impairs cognitive impairment so severely that 
symptoms present as dementia.   
In a meta-analysis of studies on the association between depression and dementia, Jorm 
(2001) offered the following hypotheses:  
Depression treatments are a risk factor for dementia; depression and dementia share 
common risk factors; depression is a prodrome of dementia; depression occurs as an early 
reaction to cognitive decline; depression brings forward the clinical manifestation for 
dementing disease, and; depression leads to damage of the hippocampus through a 
glucocorticoid cascade. (pp. 778-779)  
Recently, the association between PTSD and dementia has received much consideration 
from researchers (Lohr et al., 2015; Yaffe et al., 2010). Yaffe and colleagues (2010) reported that 
Veterans with PTSD have a twofold greater risk of developing dementia compared to Veterans 
without PTSD. An explanation for Veterans’ [with PTSD] higher risk for dementia is the co-
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occurrence of depression with both PTSD and dementia. Further, PTSD and dementia both 
involve depressive symptoms. Notably, Wild and Gur (2008) reported that even after controlling 
for comorbidity (e.g., depression, substance use, lower IQ, and inattention), PTSD was still 
associated with verbal memory deficits, which are some of the hallmark indicators of depression 
and dementia.  
Depression as a Risk Factor for Dementia 
As researchers have clearly established the existence of some type of relationship 
between depression and dementia, scholars are now examining if depression may be a potential 
risk factor for depression. The literature indicates that certain changes occurring in the brain 
(e.g., neurotransmitter changes, vascular brain disease, white matter changes, and hippocampal 
changes) support the notion that depression is indeed a risk factor for dementia (Byers & Yaffe, 
2011; Chen et al., 2008; Hirono, Kitagaki, Kazui, Hashimoto, & Mori, 2000; Korczyn & 
Halperin, 2009; Sheline, Gado, & Kraemer, 2003). In the general population, depression usually 
occurs before dementia, and it is also associated with approximately double the risk of 
developing dementia or cognitive impairments (Barnes et al., 2012). For women 65 years and 
older, compared to their male counterparts, clinically significant depressive symptoms are 
associated with greater incidence of mild cognitive impairment (MCI) and probable dementia 
(Goveas, Espeland, Woods, Wassertheil-Smoller, & Kotchen, 2011). 
Researchers are finding that the time of onset of depression may influence its relationship 
with dementia (Barnes et al., 2012; Byers & Yaffe, 2011; Geerlings, den Heijer, Koudstaal, 
Hofman, & Breteler, 2008). The onset of depression varies from individual to individual and 
there is an increase in the number of instances of depression that occur in individuals from young 
adulthood to middle age (Byers & Yaffe, 2011). Early- or mid-life depression has been identified 
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as a significant risk for dementia, whereas late-life depression may act as a prodrome of 
dementia (Barnes et al., 2012; Byers & Yaffe, 2011). Additional research is necessary to clarify 
the differences between earlier- or later-onset of depression and its relationship with dementia. 
Exploring further the impact of an earlier onset of depression could also contribute to 
preventative treatment efforts for dementia.  
PTSD as a Risk Factor for Dementia: Recent Discoveries  
Consistent with the data on comorbidity among PTSD, depression, and dementia, 
researchers have recently found assocations between PTSD and dementia, with some identifying 
PTSD as a significant risk for dementia (Lohr et al., 2015; Sandica & Pop, 2014; Wild & Gur, 
2008; Yaffe et al., 2010). Similar to depression, individuals with smaller hippocampal volume 
are at greater risk of PTSD (Sandica & Pop, 2014). Lohr and colleagues (2015) found that a 
history of PTSD is associated with accelerated aging, including a greater risk for dementia and 
other aging-related diseases. Specifically for Veterans 65 years or older, those with PTSD had 
significantly higher chances of developing dementia compared to those without PTSD (Qureshi 
et al., 2010). Moreover, even after controlling for several other disorders, researchers found that 
PTSD was still associated with lower verbal memory (Wild & Gur, 2008).  
Diversification of the Population 
Important to consider when examining prevalence rates and risk factors for the three 
disorders is the rapid diversification of the U.S. population (U.S. Census Bureau, 2008). The 
U.S. Census Bureau (2008) estimated that by 2043, ethnic minorities as a whole group will 
outnumber their White counterparts. However, each ethnic minority subgroup population within 
the larger group of minorities will continue to be smaller than the White population. The overall 
20 
 
Veteran population will decrease, yet the number of women and ethnic minority Veterans will 
increase (National Center for Veterans Analysis and Statistics (NCVAS), 2014).  
Including diverse participant samples in future research is imperative, as the existing 
literature is more representative of certain groups than others (Mindt, Byrd, Saez, & Manly, 
2010; Ramirez, Ford, Stewart, & Teresi, 2005). Further, neglecting to include diverse 
populations (e.g., women and ethnic minorities) in research may result in detrimental health 
consequences, as the U.S. population is very different than how it was just one decade ago. 
Treatment may look different from group to group, or individual to individual, men to women, 
etc. (Ramirez et al., 2005). Notably, Burchard and colleagues (2003) indicated that ignoring race 
in research and clinical practice can be rather damaging for minorities, as it overlooks or 
minimizes existing disparities and the experiences of minorities, and Oh et al. (2015) contended 
that it is a “missed scientific opportunity to fully understand the factors that lead to disease or 
health” (p. 1). Significant racial disparities relating to quality of health care and health outcomes 
also exist in the U.S.; thus, problems such as limited research findings applicable to the 
population as a whole and the lack of culturally appropriate assessments, must be addressed 
(Ramirez et al., 2005). Disparities between men and women have also been highlighted in the 
literature, with women having higher risks than men for a large number of mental conditions 
(Breslau, 2009; Kessler, 2003; WHO, 2002). 
Sex Disparities in Diagnoses 
Over a decade ago, researchers were finding that women are more likely than men to be 
diagnosed with dementia (Launer et al., 1999; Letenneur et al., 2000), and this finding is also 
accepted among most contemporary scholars (Katz et al., 2012; Mielke et al., 2014). In the 
general population, women also have higher prevalence rates of depression (Kessler, 2003; 
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Piccinelli & Wilkinson, 2000), and this pattern also has not changed in the last decade (Bouchard 
& Shih, 2013; Essau, Lewinsohn, Seeley, & Sasagawa, 2010; Van de Velde, Bracke, & 
Levecque, 2010) . The WHO (2002) provided an explanation for the sex disparities in depression 
rates, stating that the same qualities characterizing depression (e.g., “behaving in submissive 
ways, experiencing a sense of defeat, wanting to escape but being trapped, perceptions of the self 
as inferior”, and more) are the same ones that are encouraged in women as desirable qualities of 
femininity (p. 12). 
Depression prevalence rates among older men and women are inconsistent in the existing 
literature (Barefoot et al., 2001; Sonnenberg, Beekman, Deeg, & Tilburg, 2000). Barefoot and 
colleagues (2001) indicated that disparity in prevalence rates of depression between men and 
women declines in late-life, whereas Sonnenberg et al. (2000) found that prevalence rates were 
almost twice as high for women aged 55 to 85 compared to their male counterparts. Interestingly, 
Shoevers and colleagues (2000) found that although the prevalence rates of depression for 
women was double that of men, men showed higher mortality risks than women, which could be 
a possible explanation for the variability in findings. Overall, the findings indicate that women 
continue to have higher rates of depression than men in late-life, yet men experience increased 
mortality risk compared to women despite having similar depressive symptoms.  
More recently, researchers have confirmed that the female gender has consistently been 
identified as a significant risk factor for late-life depression (Chen, Chong, & Tsang, 2007; 
Meeks et al., 2011). Importantly, however, many older adults may be experiencing depressive 
symptoms, yet not meeting the full criteria for a depressive disorder (e.g., MDD or adjustment 
disorder). Depressive symptoms potentially impact these persons in a significant way, yet 
without a proper classification system, they become difficult to diagnose and treat (Chen et al., 
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2007), thus potentially leading to discrepancies in prevalence rates of depression among older 
men and women. Now, scholars use terms such as subthreshold depression, minor depression, or 
subsyndromal depression to describe such phenomena (Meeks et al., 2011).  
Considering the comorbidity of PTSD and depression, it is not surprising that women are 
at greater risk for PTSD compared to men (Frans, Rimmo, Aberg, & Fredrikson, 2005). In the 
general population, PTSD rates among women are twice as high compared to men, even though 
men report greater trauma exposure (Frans et al., 2005). Breslau (2009) indicated that women are 
more likely to develop PTSD following a traumatic incident, which could be an explanation for 
the inconsistency in prevalence rates and the number of trauma exposures found by Frans and 
colleagues (2005). These findings have noteworthy implications for women in the military, as 
they are more likely to experience trauma compared to women in the general population 
(Breslau, 2009; Haskell et al., 2010). Hence, as the female U.S. Veteran population rises, the 
prevalence rates of PTSD for this population is likely to increase as well.  
 Racial Disparities in Diagnoses  
Countless researchers have established that significant health disparities exist between 
ethnic minority and White individuals in the U.S. (Manly & Mayeux, 2004). Black individuals 
have a greater risk for dementia than White individuals, even after controlling for education, 
gender, and ApoE4 genotype (Plassman et al., 2007), which is a variant of the apolipoprotein E 
(ApoE) genotype and the most significant genetic risk for late-onset Alzheimer’s disease (AD; 
Cheng et al., 2005). From the Multi-Institutional Research in Alzheimer’s Genetic Epidemiology 
Study, Green and colleagues (2002) determined that the overall risk of dementia by age 85 was 
higher among first-degree relatives of Black individuals with AD (43.7 percent) compared to the 
risk for first-degree relatives of White individuals with AD (26.9 percent). Similarly, Shadlen 
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and others (2006) found that White individuals with low levels of education and Black 
individuals with high levels of education had twice the risk compared to White individuals with 
high levels of education. Notably, the risk for dementia increased fivefold for Black individuals 
with low education. Overall, researchers consistently suggest that Black and Hispanic individuals 
are at greater risk of developing dementia compared to White individuals (Manly & Mayeux, 
2004). It is important to note that the research is limited regarding prevalence rates of dementia 
among other racial minority groups, as the majority of the existing literature in this area involves 
Black, White, and sometimes Hispanic populations (Manly & Mayeux, 2004).  
The findings for rates of depression across racial groups, however, are not as 
straightforward as they are for dementia. Some scholars have indicated that major depressive 
disorder (MDD) is more prevalent in the White population, whereas dysthymic disorder is more 
common in Black and Mexican American populations (Riolo, Nguyen, Greden, & King, 2005; 
Williams et al., 2007). Others have stated that, among adults aged 54 to 65 years, MDD and 
other depressive factors are more prevalent in racial minority populations (Dunlop, Song, Lyons, 
Manheim, & Chang, 2003).  
Scholars provided evidence to explain the inconsistent findings in depression prevalence 
rates. McGuire and Miranda (2008) discussed how ethnicity, race, culture, and language all can 
impact symptom expressions and behaviors, as well as how health care providers interpret such 
expressions and behaviors. Due to the underrepresentation of ethnic minorities, particularly in 
medical research and care, it is likely that lower depression rates among minorities may be an 
inaccurate reflection of their experiences. Akincigil and colleagues (2012) conducted a study 
with adult Medicare patients, ranging in age from less than 45 to more than 85 years, to examine 
racial and ethnic disparities in depression care. Consistent with past research findings (Alegria et 
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al., 2008; McGuire & Miranda, 2008; Mezuk et al., 2010), the researchers concluded that ethnic 
minorities, including Black, Hispanic, and other non-Hispanic groups, were less likely to be 
diagnosed with and treated for depression, when compared to the majority group (i.e., non-
Hispanic White persons). Consequently, the researchers highlighted the “underrecognition and 
undertreatment of depression among minority elders,” as well as “the net of differences in 
underlying symptoms” (Akincigil et al., 2012, p. 323).  
Mezuk and colleagues (2010) found that Black individuals experience more life stressors 
and engage in more poor health behaviors (PHB) than White individuals, yet Black individuals 
still had a lower prevalence of depression than their White counterparts. Interestingly, when 
measuring how PHB affected the positive link between life stress and depression risk, the PHB 
of Black individuals moderated this link [between stress and depression], whereas the PHB of 
White individuals did not. These findings provide a rationale for health care providers to assess 
mental and physical health together, because racial groups may express symptoms and behaviors 
differently than others.  
The results support the relationship between social disadvantage, exposure to stress, 
coping via poor health behaviors, and the existence of mental and physical health racial 
disparities (Mezuk et al., 2010). For instance, rather than utilizing mental health treatments, it is 
possible that racial minorities cope via poor health behaviors in response to the chronic and 
higher levels of life stressors they experience (compared to their White counterparts). Mezuk et 
al. (2010) concluded that such differences in coping behaviors potentially account for racial 
disparities in health outcomes, despite lower rates of mental health diagnoses among racial 
minorities. Importantly, since the majority of the racial comparisons made in research studies 
involve Black and White populations, researchers must consider the limitations when applying 
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these findings to other racial minority groups, particularly those remaining largely 
underrepresented in the literature. 
Similar trends in prevalence rates of PTSD have also been reported. Black individuals 
had greater odds of being diagnosed with PTSD, and also had greater lifetime prevalence rates of 
PTSD compared to their White, Asian, and Hispanic counterparts (Asnaani et al., 2010). 
Unfortunately, Black individuals were less likely to seek treatment for PTSD and other mental 
health disorders, when compared to White individuals (Himle et al., 2009; Roberts et al., 2011).  
Explanations for Disparities  
Across the majority of disease categories, members of racial minority groups had higher 
morbidity and mortality rates than their White counterparts (Ramirez et al., 2005). The U.S. 
Department of Health and Human Services (2010) attributed these persisting disparities to 
barriers and discrimination that disadvantaged groups, such as women and ethnic minorities, 
encounter. In 2010, the U.S. Surgeon general proclaimed that members of ethnic and racial 
minority groups in the U.S. “face a social and economic environment of inequality that includes 
greater exposure to racism, discrimination, violence, and poverty, all of which take a toll on 
mental health” (American Psychiatric Association, 2016).  
Causes of such inequity cannot be determined by the types of studies that have been 
conducted thus far to analyze health disparities across groups, resulting in uncertainty about the 
determinants (Ramirez et al., 2005). Further, utilizing assessments that lack cultural sensitivity 
leads to misrepresentative data, particularly if norms have not yet been developed for certain 
groups (Ramirez et al., 2005). Nonetheless, scholars have offered several hypotheses in efforts to 




Health Care Providers’ Roles 
Van Ryn and Fu (2003) stated “Public health, medical care, and human service providers 
may influence race/ethnicity and class health disparities in several interconnected ways” (p. 249). 
Provider communications impact patients’ health-related cognition and behavior (e.g., lower or 
high expectations, mechanisms of access, loss of benefits; Van Ryn & Fu, 2003). For instance, 
health care providers can influence patients’ view of themselves (e.g., deservingness of 
treatment, fundamental value to the community) and their society, culture, and community (Van 
Ryn & Fu, 2003).  
Likewise, patients’ demographic characteristics (e.g., race/ethnicity, sex, age, diagnostic 
history, and sexual orientation) also significantly affect providers’ beliefs and expectations 
(Dovidio et al., 2008). This, in turn, can influence patients’ perceptions of themselves and of 
their providers (Dovidio et al., 2008; Van Ryn & Fu, 2003). Dovidio and colleagues (2008) 
emphasized the importance of considering how “potential racial biases of providers, which may 
be subtle and unintentional, and the sensitivity of Black patients to possible cues of bias jointly 
influence the nature and outcomes of the medical encounter” (p. 5).  
For instance, White physicians exhibited more verbally dominant and less patient-
centered characteristics with Black versus White patients (Johnson, Roter, Powe, & Cooper, 
2004). When working with breast cancer patients, White physicians spent much less time 
involved in relationship-building activities with Black versus White patients (Siminoff, Graham, 
& Gordon, 2006). Female patients were more likely to be diagnosed with depression than male 
patients, even if they reported or presented with identical symptoms (WHO, 2002). However, the 
source of these phenomena are difficult to identify, as personal perceptions are influenced by 
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several different contextual factors (Van Ryn & Fu, 2003). Thus, causes cannot be determined 
and the research in this area remains inconclusive.   
Another area researchers explored to understand racial health disparities are the inequities 
related to treatment. There is undertreatment of depression, that also results from 
underrecognition, among older minority adults (Akincigil et al., 2012). Researchers found that all 
racial minority groups are less likely to have access to depression treatment compared to their 
White counterparts (Alegria et al., 2008; Simpson, Krishnan, Kunik, & Ruiz, 2007). Dovidio et 
al. (2008) presented their findings from a comprehensive review of the literature on the existing 
race- and gender-related health disparities, specific racial groups’ distrust in the health care 
system, and how health care providers contribute to racial health inequities. They identified 
numerous examples of how providers’ racial biases can impact their treatment of minority 
patients. It is also important to note that in 2010, the Institute of Medicine Panel identified race-
based prejudice as a key determinant of the existing health disparities in the U.S. (U.S. 
Department of Health and Human Services, 2010).   
Neuropsychology and Universalism 
When examining conditions such as dementia, depression, and PTSD, the field of 
neuropsychology deserves mention based on the altered or impaired cognitive functioning that 
characterizes these disorders. Neuropsychologists are charged with assessing patients’ brain 
functioning to understand their cognitions and behaviors (Strauss, Sherman, & Spreen, 2006). 
Mindt and others (2010) underscored the limits to universalism in neuropsychology, which holds 
that cognitive processes are similar across all persons. The researchers contended that this notion 
is false in the context of neuropsychological functioning across diverse groups. Further, when 
universalism is accepted as true, the cognitive processes of the founder(s) of the field become 
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regarded as “normal,” and cognitive processes departing from the founders’ are considered 
abnormal, impaired, or pathological.  
Applying the notion of universalism in neuropsychology has been detrimental for racial 
minorities due to their underrepresentation as patients and providers in the field (Manly, 2008; 
Mindt et al., 2010). Although the research on minorities’ cognitive test performance is 
increasing, the clinical tools and guidelines for neuropsychological assessment of these groups, 
especially American Indian and Alaska Native individuals, are very limited (Manly, 2008). 
Hence, neuropsychologists are faced with a dilemma when working with ethnic minority 
patients; it is well known that it is unethical to use inappropriate measures with culturally 
different individuals, yet refusing service for large groups of people based on demographic 
characteristics also violates the field’s ethics. In addition to the existing racial health disparities 
in the general U.S. population, there are disparities in the availability and/or use of 
neuropsychological services, resulting in an increased risk for minorities not receiving the 
appropriate diagnosis or treatment. Neuropsychology, along with several other health 
subspecialty fields, require further vigorous testing of its approaches and methods to assure equal 
health access, assessment, and treatment across racial groups.   
Differences in Coping Mechanisms  
The literature shows how different groups of people use varying coping mechanisms for 
their health problems, which scholars hypothesize may be playing a role in the existing health 
disparities (Ford & Airhihenbuwa, 2010; Gerrard et al., 2012). For example, women are more 
likely to go to their primary care physician for mental health problems, whereas men are more 
likely to go to a mental health specialist (WHO, 2002). Moreover, people’s expectations based 
on gender can influences their disclosure of health information. For example, men are more 
29 
 
likely to disclose alcohol or drug usage, whereas women are more likely to disclose emotional 
problems (WHO, 2002), as these problems prove to be more stereotypically accepted for men 
and women, respectively. With respect to racial differences in coping mechanisms, historical 
events, socioeconomic status, and cultural or religious beliefs can play a major role. For 
example, Conner and others (2010) determined that due to a lifetime of discrimination and 
racism experienced by older Black adults, their lack of trust in the health care system often 
results in them seeking culturally endorsed strategies to “push through” (p. 979) the problem, 
rather than seeking official medical care for potentially serious medical conditions. Gerrard et al. 
(2012) also highlighted how adverse experiences, such as racial discrimination, can influence 
racial minorities’ to use illicit substances as a method of coping.  
The Public Health Critical Race (PHCR) Praxis 
In an attempt to explain racial disparities in health care, Ford and Airhihenbuwa (2010) 
developed the Public Health Critical Race (PHCR) Praxis, which was adapted from Critical Race 
Theory (CRT; Delgado, Stefancic, & Liendo, 2012). The researchers identified PHCR as a tool 
to promote health equity that “combines theory, experiential knowledge, science, and action” to 
actively counter existing health inequities (Ford & Airhihenbuwa, 2010, p. 1391). Although 
segregation and other overt forms of discrimination are outlawed, subtle forms of discrimination, 
such as “not being offered the same follow-up care that other patients are offered” are common 
occurrences today (Thrasher, Clay, Ford, & Stewart, 2012, p. 1025). PHCR demonstrates how 
negating to consider race in health care research and clinical work dismisses the systemic and 
institutional racism that largely prevails in the U.S. today, thus, turning the disparities into the 
result of characteristics or deficits of certain groups (e.g., focusing on race as a biological 
category). The researchers give emphasis to the importance of race consciousness via four 
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primary foci: contemporary patterns of racial relations, knowledge production, conceptualization 
and measurement, and action (Ford & Airhihenbuwa, 2010). The model can be applied in 
research and clinical practice across various contexts (e.g., gender inequities) to demonstrate 
how such inequities are perpetuated in the current system and the PHCR would be an invaluable 
tool for examination of racial inequalities across health-related contexts.  
Veteran Population 
There are approximately 21 million Veterans in the U.S., 72 percent of whom are 50 
years or older (National Center for Veterans Analysis and Statistics (NCVAS), 2014). Further, 
the number of women and ethnic minority U.S. Veterans is steadily rising. The National Center 
for PTSD reported that the lifetime prevalence of PTSD is significantly higher among Veterans 
compared to American adults in the general population (Gradus, 2007). Among all adults, the 
lifetime prevalence of PTSD is estimated to be 3.6 percent for men and 9.7 percent for women. 
In the Veteran population, the lifetime prevalence is 30.9 percent among men, and 26.9 percent 
among women. Researchers determined that Veterans with PTSD are twice as likely to develop 
dementia when compared with Veterans without PTSD (Yaffe et al., 2010). Yaffe and colleagues 
(2010) reported that both PTSD and dementia are associated with a higher co-occurrence risk of 
depression. Parallel patterns of disparities in health care and outcomes exist within the Veteran 
population (Ramirez et al., 2005). Based on these findings, Veterans have higher risks for PTSD, 
as well as depression and dementia, hence, making them an important group to study (Shively & 
Perl, 2012; Sibener et al., 2014). 
Summary and Conclusions  
Despite proliferation of research in the area, the relationship between depression, PTSD, 
and dementia remains uncertain. Dementia affects 3.4 million individuals aged ≥ 71 years in the 
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U.S. and people’s risk for dementia increases by age (Plassman et al., 2007). Although age has 
been identified as the biggest risk factor for dementia, there are no current methods for health 
care providers to utilize to determine with certainty whether an individual will later develop 
dementia. Importantly, researchers provided evidence that the pathophysiological changes 
associated with dementia, specifically Alzheimer’s disease, starts much earlier than when overt 
symptoms are observed (Sperling et al., 2011). Sperling and colleagues (2011) identified this 
earlier stage as “preclinical”, and stressed that it would be one of the most critical opportunities 
for intervention (i.e., preventative methods).  
Exploring the role of depression and PTSD in predicting dementia would be 
advantageous in providing additional information on what types of symptoms individuals may 
exhibit in the “preclinical” stage. Depression is the most common mental health problem 
encountered by women, and it is the most notable contributor to the worldwide burden of disease 
(Essau et al., 2010; WHO, 2002). Importantly, a large body of evidence shows that a history of 
depression doubles the risk of dementia (Barnes et al., 2012). PTSD is more common in the U.S. 
than in other countries, especially following the September 11 attacks and Operation Iraqi 
Freedom (OIF) and Operation Enduring Freedom (OEF) in Iraq and Afghanistan, respectively. 
Due to the recent literature in which researchers identify PTSD as a risk factor for accelerated 
aging (which includes increased risk for dementia; Lohr et al., 2015; Sibener et al., 2014) and the 
increasing minority population of U.S. Veterans (U.S. Census Bureau, 2008), PTSD also proves 
to be an important disorder to consider when studying dementia.   
The population is rapidly changing and health care providers must develop and maintain 
cultural competency with regard to assessment, diagnosis, and treatment. In addition to the 
known risk factors of dementia, scholars have also demonstrated how race and sex may play a 
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role in assessment, diagnosis and treatment of dementia and related conditions. Compared to 
their White counterparts, racial minorities encounter additional barriers when attempting to 
access health care, which then directly affects health outcomes. This also proves to be true 
among Veterans, as persons in this group are at greater risk of developing dementia compared to 
non-Veterans (Sibener et al., 2014). Due to the complex relationship among the three conditions 
and societal factors unique to the Veteran population that may influence health care and 
outcomes, additional research is needed to better understand psychiatric risk factors of dementia 
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The objective of this study was to investigate major depressive disorder (MDD) and 
posttraumatic stress disorder (PTSD) first diagnosed at age < 55 years, as predictors of dementia 
and other forms of cognitive impairment not demented (CIND) in Veteran subjects aged ≥ 60 
years (N = 4,800). Sex (male or female) and race (Black or White) were analyzed as potential 
moderators. Based on the literature, it was hypothesized that subjects with MDD or PTSD 
history would have an increased risk of dementia/CIND compared to those without a history. 
Hypotheses related to sex and race were exploratory. There were twelve groups in this study, 
determined by psychiatric history (e.g., MDD, PTSD, or no psychiatric history), sex, and race. 
Two sets of hierarchical and backward logistic regression analyses were conducted to determine 
significant predictors of dementia/CIND. The outcome variable in the first set of analyses was 
dementia/CIND diagnosed at age ≥ 60, and the findings of these data were largely insignificant. 
In the second set of analyses (dementia/CIND diagnosed at age ≥ 56), a history of MDD or 
PTSD both were associated with almost double the risk for developing dementia/CIND. When a 
history of MDD was indicated, Black Veterans’ risk of dementia/CIND increased almost 
twofold. Further, given the differences in results from the first and second set of analyses, it is 
probable that Veteran subjects began experiencing dementia and cognitive impairment at an 
earlier age compared to the general population. Additional findings, limitations, and implications 
are also discussed. 






History of MDD and PTSD as Risk Factors for Dementia and Cognitive Impairment Not 
Demented (CIND) among U.S. Veterans: A Retrospective Cohort Study  
based on Demographic Characteristics 
Dementia and depression have a complex relationship, and this relationship has been 
receiving increased attention in the existing literature (Dotson, Beydoun, & Zonderman, 2010; 
Korczyn & Halperin, 2009). Due to the similarity between the two diagnoses, particularly the 
cognitive symptoms (e.g., reasoning and memory), one is commonly misdiagnosed as the other 
(Casey, 2012). Both disorders are common occurrences in older individuals. Dementia is most 
common among adults aged ≥ 65 years, and older adults are at risk for depression due to age-
associated neurobiological changes, stressful events, role changes associated with loss, and more 
(Fiske, Wetherell, & Gatz, 2009). Depression can possibly be a reaction to individuals 
experiencing a decline in memory, or it can also be an early symptom of dementia; thus, it is 
unclear if one can cause the other (Korczyn & Halperin, 2009).  
More recently, researchers have been studying the relationship between posttraumatic 
stress disorder (PTSD) and dementia, as symptoms of PTSD are related to depression and 
depression has been known to co-occur with PTSD. Notably, Yaffe et al. (2010) found that 
Veterans with PTSD have a two-fold higher risk of developing dementia when compared to 
Veterans without PTSD, which can be explained by the co-occurrence of depression associated 
with both PTSD and dementia. Likewise, Lohr et al. (2015) conducted a comprehensive review 
of empirical studies examining PTSD and the role it plays in aging, and determined that in a 
majority of studies, persons with PTSD have an increased risk of comorbidity of dementia, as 
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well as several other conditions associated with aging (e.g., cardiovascular aging, type 2 
diabetes, and gastrointestinal ulcer disease).   
Cognitive Impairment Not Demented (CIND) 
 It is worthwhile to note that conditions involving cognitive impairment extending beyond 
memory difficulties have been a significant focus of researchers in recent years (Albert et al., 
2011; McKhann et al., 2011; Yaffe et al., 2011). Across research and clinical populations, 
professionals are noticing large numbers of individuals experiencing cognitive difficulties, yet do 
not meet criteria for dementia (Chodosh, Kado, Seeman, & Karlamangla, 2007; Farias, Mungas, 
Reed, Harvey, & DeCarli, 2009; Yaffe et al., 2011). Hence, data on diagnostic and evaluative 
criteria for various forms of cognitive impairment, such as cognitive disorder not demented 
(CIND) and mild cognitive impairment (MCI), have proliferated in the literature (Albert et al., 
2011; Rosenberg, Johnston, & Lyketsos, 2006). Researchers identified persons meeting criteria 
for cognitive impairment not demented (CIND), such as MCI, as having an increased risk of 
developing dementia compared to those without CIND (Meyer, Xu, Thornby, Chowdhury, & 
Quach, 2002; Rosenberg et al., 2006). 
 Reisberg and Gauthier (2008) found, from a thorough review of the literature, that 
subjective cognitive impairment (SCI) is a stage prior to mild cognitive impairment (MCI), 
which then increases odds for the eventual development of dementia. Considering these data, 
researchers have been highlighting the importance of recognizing deficits in a range of cognitive 
functions across research and clinical settings (Katz et al., 2012). Such findings also demonstrate 
that patients reporting cognitive difficulties, although unobservable to providers and/or loved 
ones, are an important group to target for preventative treatment. 
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Further, deficits in cognitive functioning (not classified as dementia) are important to 
examine when studying the impact of psychiatric disorders (Byers, Covinsky, Barnes, & Yaffe, 
2012; Casey, 2012; Yaffe et al., 2010). A greater cumulative burden of depression, including 
more severe and chronic symptoms, has been linked with a higher likelihood of cognitive 
impairment (Kaup et al., 2016). More chronic and severe depressive symptoms are the hallmark 
features of major depressive disorder (MDD), which is a condition specifically identified as a 
key predictor of dementia (Byers & Yaffe, 2011). In fact, Byers et al. (2012) reported that 
dementia and mortality are two outcomes that are associated with MDD, yet they remain largely 
underrecognized. PTSD is also associated with an increased risk of dementia, and well as overall 
worse cognitive performance particularly in domains of processing speed, learning/memory, and 
executive functions (Lohr et al., 2015).  
Chronic Stress: The Link between MDD and PTSD 
A characteristic found in both MDD and PTSD is the presence of chronic stress (Butters 
et al., 2008; Veitch, Friedl, & Weiner, 2013). Due to its link in many different facets of the aging 
process (Lohr et al., 2015), chronic stress connects MDD with PTSD as substantial risk factors of 
dementia and other forms of cognitive impairment. For example, in the U.S., military 
deployment has been linked to chronic and acute stress, and MDD and PTSD are the two most 
common mental health illnesses found in the military and Veteran population (Veitch et al., 
2013).  
Neurotransmitter changes, vascular brain disease, white matter changes in the brain, and 
hippocampal changes also provide evidence regarding how MDD, and other forms of depression, 
may be a risk factor for dementia/CIND (Byers & Yaffe, 2011; Chen et al., 2008; Hirono, 
Kitagaki, Kazui, Hashimoto, & Mori, 2000; Korczyn & Halperin, 2009; Sheline, Gado, & 
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Kraemer, 2003). Scholars are finding that early-life and mid-life (40 to 55 years of age) 
depression may act as a significant risk-factor for dementia and related conditions, whereas late-
life depression may act as a prodrome for dementia (Barnes et al., 2012; Byers & Yaffe, 2011; 
Geerlings, den Heijer, Koudstaal, Hofman, & Breteler, 2008). Similar conclusions have been 
reported for persons with a history of PTSD, which is not surprising considering the high 
comorbidity between the two disorders (Angelakis & Nixon, 2015; Spinhoven, Penninx, van 
Hemert, de Rooij, & Elzinga, 2014). For example, persons with MDD and those with PTSD were 
found to have smaller hippocampal volume; however, it remains unclear whether this leads to 
symptoms or such symptoms lead to decreased hippocampal volume (Byers & Yaffe, 2011; 
Sandica & Pop, 2014). 
Changes in the Population  
An important aspect to consider when studying relationships between dementia and 
related conditions is the rapidly changing demographic characteristics of the U.S. population. 
The U.S. Census Bureau (2008) projected that ethnic minorities will become the majority group 
by 2043, rising from about 33 to 54 percent of the country’s population. However, since some of 
these groups are underrepresented in research, there is a strong necessity to include diverse 
populations in studies in order to deliver up-to-date information to health care providers, as well 
as the general public (Mindt, Byrd, Saez, & Manly, 2010; Ramirez, Ford, Stewart, & Teresi, 
2005). Due to this underrepresentation, the research is somewhat limited, and inconsistent, 
regarding prevalence rates of certain diagnoses among diverse groups.   
Similar to the general population, the U.S. Veteran population is also expected to become 
more diverse. The National Center for Veterans Analysis and Statistics (NCVAS; 2014) 
published the Projected Veteran Population 2013 to 2043 report demonstrating that, although the 
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size of the Veteran population is predicted to decline, the percentage of female and ethnic 
minority Veteran population will gradually increase. Thus, as this population increases, there is a 
growing need for health care providers who are competent in working with diverse individuals. 
Veterans are an important group to study, as scholars have identified them as having greater risk 
for dementia/CIND than the general population (Lohr et al., 2015; Shively & Perl, 2012; Sibener 
et al., 2014). For example, increased age, Black racial background, and other disorders of the 
brain (e.g., depression) have been recognized as some of the key risk factors of dementia and 
related cognitive deficits (Lohr et al., 2015; Shively & Perl, 2012). Compared to the general U.S. 
population, the Veteran population, on average, consists of older individuals, greater proportion 
of Black individuals, and has higher incidence rates of TBI and PTSD, which are also related to 
depression (Sibener et al., 2014).  
Prevalence Rates  
Dementia and CIND 
General Population. Among persons aged ≥ 60 years, the estimated prevalence rate of 
dementia worldwide is between 5 to 7 percent (Prince et al., 2013). Scholars have reported 
varying rates of dementia across demographic groups in the U.S. (Hebert, Weuve, Scherr, & 
Evans, 2013; Manly & Mayeux, 2004; Plassman et al., 2007). The findings from the Aging, 
Demographics, and Memory Study (the ADAMS study; Plassman et al., 2007) indicated that 
among participants aged ≥ 71 years, Black individuals were at a greater risk for dementia than 
White individuals even after controlling for education, gender, and ApoE4 genotype. The ApoE 
(apolipoprotein E) genotype has three major alleles, with variant E4 being the largest genetic risk 
factor of late-onset Alzheimer’s disease (AD; Cheng et al., 2005; Reddy & Beal, 2008).  
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The ADAMS study results did not indicate significant differences in rates of dementia 
between men and women (Plassman et al., 2007). Nonetheless, other studies have long 
demonstrated the increased risk for women in the general population for developing dementia 
(Viña & Lloret, 2010). For instance, Mielke, Vemuri, and Rocca (2014) reported that women are 
disproportionally affected by dementia, particularly Alzheimer’s disease, and it is possible men 
are more likely to be impacted by mild cognitive impairment (MCI). Other scholars have found 
that women have an increased risk for dementia compared to men at age ≥ 90 years, and that 
dementia rates among men and women younger than 90 were not significantly different (Katz et 
al., 2012). 
CINDs have been difficult to measure due to lack of diagnostic clarity (Albert et al., 
2011). To illustrate, Plassman et al. (2008) found estimates ranging from 3 to 29 percent from a 
comprehensive review of the literature. In their study, they found cognitive impairment to be 
present in 22.2 percent of individuals aged ≥ 71 years, which is approximately 70 percent higher 
than the rate of dementia (Plassman et al., 2008). The researchers also reported that compared to 
women, men were at a greater risk of having CIND. They did not find a significant relationship 
between racial background and CIND (Plassman et al., 2008).  
Veteran Population. Dementia rate estimates vary slighty for the Veteran population, 
yet they are largely consistent with the rates (5 to 8 percent) reported for the general population 
(Veitch et al., 2013; Wray, Wade, Beehler, Hershey, & Vair, 2014). Across disciplines, 
researchers are expecting this rate in the Veteran population to increase due to the aging 
population of the U.S. Specifically, among persons aged ≥ 60 years in the general U.S. 
population, 22 percent are Veterans. Moreover, half of the men in this population are Veterans. 
Due to the significant amount of comorbidity found in mental and cognitive disorders in this 
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population, CIND rates have not clearly been established but are thought to follow similar trends 
(Veitch et al., 2013). 
Depression and PTSD 
General Population. The lifetime prevalence rate of MDD in the general population is 
between 5.2 to 6.7 percent (Veitch et al., 2013). Researchers indicated that White individuals 
have higher rates of MDD whereas Black and Mexican American individuals have higher rates 
of dysthymic disorder, which involves a chronic state of dysphoria (Riolo, Nguyen, Greden, & 
King, 2005; Williams et al., 2007). Riolo and colleagues (2005) attributed this to possible effects 
of poverty, lack of education, less access to health care, and more. However, for adults between 
54 to 65 years of age, Dunlop, Song, Lyons, Manheim, and Chang (2003) found that MDD and 
associated factors were more prevalent in ethnic minority populations than White populations. 
Thus, although some literature exists that estimates the rates of these disorders across minority 
groups, the research is scant, and sometimes contradictory, due to small sample sizes across 
specific groups, lack of culturally appropriate measures, and more (Ramirez et al., 2005).  
Among men and women, scholars determined that women generally have greater rates of 
depression compared to their male counterparts (Essau, Lewinsohn, Seeley, & Sasagawa, 2010; 
Piccinelli & Wilkinson, 2000; Van de Velde, Bracke, & Levecque, 2010). Such differences could 
be attributed to various factors, including but not limited to societal and cultural gender norms, 
higher risk of certain traumatic incidents, help seeking tendencies, and more (Bouchard & Shih, 
2013). Among older adults aged ≥ 65 years, the data on rates of depression is inconsistent 
(Djernes, 2006). Barefoot, Mortensen, Helms, Avlund, and Schroll (2001) found that the 
disparity in rates of depression decreases in late-life, whereas Hybels, Blazer, and Pieper (2001) 
reported that among persons aged > 65 years, women consistently had greater rates of depression 
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compared to men. Similarly, among persons 55 to 85 years of age, the prevalence rate of 
depression in women was almost twice as high as it was for men (Sonnenberg, Beekman, Deeg, 
& Tilburg, 2000). Schoevers and others (2000) also found the rate of depression for women was 
double that for men, though men showed higher mortality risks than women amongst persons 
with severe levels of depression. More recently, researchers have determined that the female 
gender acts as a prominent risk factor for late-life depression (Meeks, Vahia, Lavretsky, 
Kulkarni, & Jeste, 2011).   
There is a higher prevalence of PTSD in the U.S. compared to other countries, with 
lifetime prevalence rates of 6 to 12 percent in the general population (Breslau, 2009; Veitch et 
al., 2013). Men reported experiencing more traumatic incidents than do women, yet women were 
twice as likely as men to develop PTSD after a traumatic incident (Breslau, 2009; Dobie et al., 
2004). In the general population, Black individuals were more likely to have PTSD compared to 
their White counterparts, and all ethnic minorities were less likely to seek treatment for PTSD 
compared to White individuals (Asnaani, Richey, Dimaite, Hinton, & Hofmann, 2010; Roberts, 
Gilman, Breslau, Breslau, & Koenen, 2011). Furthermore, Black persons in the general 
population have higher lifetime prevalence rates of PTSD compared to other racial groups 
(Himle, Baser, Taylor, Campbell, & Jackson, 2009). 
Veteran Population. The Veteran population has greater prevalence rates of mental 
health diagnoses compared to the general population, with MDD and PTSD being the most 
common (Veitch et al., 2013). The lifetime prevalence of PTSD among U.S. combat Veterans is 
between 6 to 31 percent, which is significantly greater than the rate of 6 to 12 percent for the 
general population. Compared to active duty Veterans aged > 40 years, Veterans aged < 25 have 
a greater risk for PTSD (Seal et al., 2009). The rates of MDD in the Veteran population has been 
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difficult to measure, with estimates ranging from 12 to 30 percent (Veitch et al., 2013). Female 
Veterans have been found less likely to screen positive for PTSD, yet more likely to screen 
positive for depression and military sexual trauma (Haskell et al., 2010). Dobie et al. (2004) 
found a 21 percent prevalence rate of PTSD for female Veterans, and 20 percent for male 
Veterans; however, additional research is necessary to determine more accurate estimates 
between male and female Veterans.  
In their analysis of a subsample of Veterans from the National Vietnam Veterans 
Readjustment Study (NVVRS), Dohrenwend, Turner, Turse, Lewis‐Fernandez, and Yager (2008) 
found that Black Veterans had elevated rates of chronic PTSD, which they explained could 
potentially be due to greater exposure to war-zone stressors. Black persons were also identified 
as having a greater risk in a study of Veterans involved in recent Operation Enduring 
Freedom/Operation Iraqi Freedom conflicts (Dursa, Reinhard, Barth, & Schneiderman, 2014). 
Importantly, Villa (2002) determined that Black Veterans have continually been disadvantaged 
with respect to health and other factors associated with daily living across all war cohorts prior to 
Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn 
(OND). 
The comorbidity of MDD and PTSD among Veterans has been an important topic for 
researchers, as the exact relationship between the two has been described as “likely to be 
complex, involving bidirectional causality, common risk factors, and common vulnerabilities” 
(Angelakis & Nixon, 2015, p. 2). As two of the most common mental health disorders found in 
this population, it is not a surprising finding that the comorbidity rates of MDD and PTSD is 




Role of Sex and Race  
Examining the role of sex and race in dementia/CIND diagnosis is crucial due to the 
enduring health disparities that exist among these groups. However, the literature is lacking 
consistent data on prevalence rates of dementia and many other major conditions across different 
populations (Katz et al., 2012). The U.S. Department of Health and Human Services (2010) 
published the National Healthcare Disparities Report 2010, and found that although quality of 
health care in the U.S. is improving, access and disparities are not improving. Such disparities 
were related to disadvantaged groups based on race, SES, and more.  
Specifically, Black, American Indian, and Alaska Native individuals received worse care 
compared to their White counterparts in almost half of the core measures of health care (e.g., 
preventative care, chronic disease management). Fewer than 20% of these disparities showed 
evidence of lessening between periods ranging from 2000-2002 to 2006-2008. For example, the 
quality of and access to preventative care related to women’s health (e.g., mammograms, pap 
smears) worsened over time. Further, the U.S. D.H.H.S. (2010) underscored how racial and 
ethnic minorities, as well as persons from low SES backgrounds, often receive lower quality of 
care and encounter more barriers when trying to access health care.  
Regrettably, similar patterns of racial disparities in health care and health outcomes have 
been found among Veterans (Ramirez et al., 2005; Saha et al., 2008). For example, Saha et al. 
(2008) found worse quantity and quality of health care for racial minorities, particularly Black 
Veterans, across many clinical content areas (e.g., arthritis/pain management, heart and vascular 
disease, mental health/substance abuse, and more) as well as by utilization or outcome measure 
(e.g., medication prescribing and adherence, basic services and processes of care, intermediate 
outcomes, patient care, and more).  
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Providers’ diagnostic and treatment decisions were also found to vary based on patients’ 
race (Lagomasino, Stockdale, & Miranda, 2015). Ramirez and colleagues (2005) asserted that 
among the Veteran and the general populations, older racial minority groups have higher 
incidences of several diseases (e.g., hypertension, heart disease, diabetes, and more) compared to 
their White counterparts. It is important to note that scholars have also identified studies based 
on secondary and administrative Veterans Health Administration (VHA) data that are often 
missing race/ethnicity data (Long, Bamba, Ling, & Shea, 2006), leaving researchers with an 
incomplete picture of existing disparities.  
Patients’ Demographic Characteristics and Providers’ Impressions 
Patients’ demographic features were found to be associated with variations in providers’ 
diagnostic and treatment impressions, which researchers have recognized as one of the leading 
causes of the existing health disparities (Alarcón et al., 2009; Gara, Vega, Arndt, & et al., 2012; 
Hyde, Mezulis, & Abramson, 2008). It is widely known now that women under 65 are more 
likely to be diagnosed with depression than men, which can be attributed to various factors, such 
as emotional expression, gender stereotypes, willingness to seek help, and more (Angst et al., 
2002; Hyde et al., 2008). Health care providers are more likely to diagnose women with 
depression compared with men, even when they report similar symptoms (WHO; World Health 
Organization, 2002). It is also probable that women are more likely to be diagnosed with 
depression and dementia due to their increased willingness to express emotion-related 
symptomology and help-seeking behaviors compared to their male counterparts (Hyde et al., 
2008). For greater diagnostic accuracy, it is important for researchers and clinicians to consider 
how sex many influence their impressions and conclusions, particularly because many conditions 
such as depression and dementia have similar symptoms. 
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Race is another important demographic variable for researchers and clinicians to 
consider, particularly because racial health disparities have persisted in the U.S. for many 
decades (U.S. Department of Health and Human Services, 2010). For example, many scholars 
have provided evidence for the greater risk of misdiagnosis that Black individuals have 
compared to other racial groups (Alarcón et al., 2009; Neighbors, Trierweiler, Ford, & Muroff, 
2003). In a seminal article by Neighbors and colleagues (2003), Black individuals were more 
likely to be diagnosed with schizophrenia whereas White individuals were more often diagnosed 
with mood disorders. Since then, the examination of how patients’ race/ethnicity influences 
providers’ diagnostic impressions has grown in the literature (Dovidio et al., 2008; Gara et al., 
2012; Lagomasino et al., 2015; McLean et al., 2014). Notably, almost one decade later, Gara et 
al. (2012) found that “clinicians appeared to minimize the possibility of mood disorder diagnosis 
or failed to carefully apply the diagnostic criteria of these disorders” for Black individuals, and 
also that symptoms were interpreted as “psychotic” for Black persons more than for other racial 
groups (p. 598). In another study, Eack, Bahorik, Newhill, Neighbors, and Davis (2012) reported 
that providers’ perceptions of patients’ honesty was significant in predicting a schizophrenia 
diagnosis only among Black individuals. Findings such as these have significant implications in 
health care (Oh, Galanter, Thakur, Pino-Yanes, Barcelo, et al., 2015).  
Interestingly, Kales and others (2005) contended that providers may also be forming 
diagnostic impressions based on factors related to socioeconomic status (SES) of certain groups, 
rather than racial characteristics. Indeed, the National Health Disparities Report 2010, reported 
that individuals of lower SES encounter barriers to accessing health care, and also receive lower 
quality of care (U.S. D.H.H.S., 2010, p. 214). However, Diemer and Ali (2009) asserted that due 
to the intertwining of socioeconomic status and race in historical and contemporary U.S. society, 
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it is difficult to disentangle the complex relationship between the two. Hence, ignoring 
racial/ethnic background and/or highlighting other factors instead that are nevertheless related to 
race (e.g., SES), can be rather detrimental, as apparent racial disparities have persisted across 
varying health care contexts for numerous decades (Burchard et al., 2003; Oh, Galanter, Thakur, 
Pino-Yanes, White, et al., 2015). Researchers have also emphasized the damage that it can cause 
for minority populations because they are already underrepresented in research (Burchard et al., 
2003; Mindt et al., 2010). Ignoring race/ethnicity in research would minimize such inequities and 
the experiences of ethnic minority group members, thus hindering the progress that has been 
made thus far in eliminating racial disparities in the U.S. health care system (Burchard et al., 
2003; Oh, Galanter, Thakur, Pino-Yanes, White, et al., 2015).  
Objectives and Rationale of the Present Study 
The objectives of this study included: (1) examine major depressive disorder (MDD) and 
posttraumatic stress disorder (PTSD) as predictors of dementia/CIND, and; (2) explore how sex 
and race moderated the relationship between the disorders. The acronym CIND (cognitive 
impairment not demented) is used to identify diagnoses primarily characterized by cognitive 
impairment selected for this study (see Appendix A for a complete list). Although definitions are 
slightly varied across studies, researchers commonly use CIND to denote cognitive decline and 
“mild impairment on memory tests and/or other cognitive domains, with at least most mild 
functional impairment in daily activities” (Williams, Plassman, Burke, Holsinger, & Benjamin, 
2010, p. 29).  
The objectives were based on the following rationale: (1) the relationship between MDD 
and PTSD with dementia/CIND is still not clear (Williams et al., 2010; Wilson, Arnold, Beck, 
Bienias, & Bennett, 2008); (2) the general population (U.S. Census Bureau, 2008) and the 
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Veteran population (NCVAS, 2014) are rapidly diversifying; (3) racial minorities experience 
lower quality of health care and additional barriers to access of health care, compared to their 
White counterparts (U.S. Department of Health and Human Services, 2010; Yaffe et al., 2013), 
and this has been found in the Veteran population as well (Saha et al., 2008), and; (4) patients’ 
demographic characteristics may influence health care providers’ diagnostic impressions and 
treatment (Dovidio et al., 2008).  
The participants of this study were U.S. Veterans, as this group has a higher likelihood of 
developing dementia/CIND when compared to the general population, particularly due to the 
unique circumstances they encounter (e.g., greater incidents of traumatic brain injury and PTSD; 
Lohr et al., 2015; Shively & Perl, 2012; Sibener et al., 2014). Racial health disparities have been 
found across a wide range of clinical service areas within the VA system, despite being a system 
where financial barriers are minimized (Saha et al., 2008). Importantly, race/ethnicity 
information has been missing from VHA data in past decades (Long et al., 2006), and this study 
intended to aid in efforts to close this gap. The existing literature on U.S. Veterans’ risk of 
dementia/CIND includes largely male samples, who predominantly self-identify as White (Byers 
et al., 2012; Yaffe et al., 2013). Research on female Veterans has increased in recent years, yet 
due to the missing data on race/ethnicity, it has been a difficult task for researchers to include a 
sample that is representative of different racial groups (Long et al., 2006). This is particularly an 
important endeavor for future researchers as the Veteran population increasingly diversifies.  
Based on the existing literature, it was hypothesized that Veteran subjects with a history 
of MDD or PTSD at age < 55 would have a greater likelihood of receiving a diagnosis of 
dementia/CIND at age > 55, compared to subjects without a history of MDD or PTSD. The 
predictive utility of race and sex were also analyzed. Further, the relationship between these 
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factors and the chronicity (i.e., number of years since the first diagnosis) of MDD and PTSD was 
assessed. 
Methods 
This was a retrospective cohort study consisting of a review of Veterans’ medical 
records, which were obtained through  the Department of Veterans Affairs (VA) Informatics and 
Computing Infrastructure (VINCI; U.S. Department of Veterans Affairs, 2014) and the 
Corporate Data Warehouse (CDW). The purpose of VINCI is to provide researchers with access 
to integrated national VA datasets, while ensuring Veterans’ privacy and data security. A 
Veteran’s data is entered into the VA database through Veterans Health Information Systems and 
Technology Architecture (VISTA), and/or the Computerized Patient Record System (CPRS). It 
is then stored nightly in the CDW, and VINCI is then used to extrapolate information from 
patient medical records as stored in the CDW.  
Based on the inclusion and exclusion criteria outlined below, the final dataset for this 
study consisted of 4,800 Veterans’ medical records retrieved via Microsoft SQL Server in the 
VINCI workspace. Structured Query Language (SQL), a standard interactive programming 
language designed for managing and manipulating data in relational database management 
systems, was used to select and organize relevant data. Veteran information (e.g., age, race, sex, 
and marital status) were retrieved from consolidated datasets from national clinical and 
administrative VA data sets (U.S. Department of Veterans Affairs, 2014).  
Data related to Veterans’ diagnostic history (e.g., ICD-9 codes and descriptions and dates 
of diagnosis) used for this study were obtained specifically from Veterans’ outpatient visits at 
VA medical centers across the nation. The visits were from a variety of clinical service areas, 
such as psychiatry or psychology (individual or group treatment methods). Generally, only 
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licensed independent providers (LIP) can generate new diagnoses for Veterans. Other service 
providers, such as social workers, can verify that their work with a Veteran targeted a given 
diagnosis. Inpatient diagnoses were not included given that it is typically mandated for all 
Veterans with inpatient visits to have a follow-up outpatient visit within seven days of their 
discharge from the inpatient unit.  
Inclusion and Exclusion Criteria 
According to the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-
5), the prevalence rates of dementia, across all subtypes, gradually increase with age for 
individuals aged ≥ 60 (American Psychological Association [APA], 2013). Taking this into 
consideration, the following inclusion criteria were applied: (1) Veterans aged ≥ 60 years [born 
before January 1, 1954]; (2) Veterans who identified as male or female; and (3) Veterans who 
self-identified as having a Black or White racial background. Secondarily, for each of the four 
groups (sex by race), subjects were included who met the following criteria at age < 55 years: (1) 
diagnosed with MDD, or (2) diagnosed with PTSD, or (3) had no psychiatric history (ICD-9 
codes 290.00 to 319.00). 
Exclusion criteria for this study included: (1) Veterans aged < 60 years [born after 
January 1, 1954]; (2) Veterans diagnosed with dementia/CIND at age < 56, (3) Veterans who did 
not self-identify as either Black or White; (4) Veterans who did not fit into the three identified 
groups based on psychiatric history (e.g., second set of inclusion criteria outlined above), and; 
(5) Veterans aged ≥ 60 years were excluded from the study if they were diagnosed with MDD or 
PTSD at age ≥ 55.  
Classifications of dementia and CINDs (Appendix A), depression (Appendix B), and 
PTSD (Appendix B) were outlined using the International Classification of Diseases, Ninth 
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Revision (ICD-9; Centers for Disease Control and Prevention, 2011) because the ICD-9 was used 
by VA employees nationwide for coding diagnoses prior to October 1st, 2015. Veterans who did 
not meet diagnostic criteria based on the ICD-9 codes listed in Appendix A and Appendix B 
were excluded from the study, such as Veterans diagnosed with any other mental health 
condition (e.g., bipolar disorder or schizophrenia) at age < 55. 
The second exclusion criteria (i.e., Veterans diagnosed with dementia/CIND at age < 56) 
was defined in order to maintain at least a one year gap between the first MDD or PTSD 
diagnosis and the first dementia or CIND diagnosis, thus allowing for the analysis of the 
predictive utility of MDD and PTSD. Although dementia generally increases in persons aged ≥ 
60 years, researchers have highlighted the larger prevalence rates of CINDs in the population, 
which is seen prior to dementia onset (Williams et al., 2010). Persons with CINDs are at a 
greater risk of developing dementia compared to those without (Artero, Petersen, Touchon, & 
Ritchie, 2006; Visser, Kester, Jolles, & Verhey, 2006).  
There are more people in the general and Veteran populations with pathological cognitive 
decline than persons diagnosed with dementia, and due to their increased risk, they are an 
important group to include in research (Artero et al., 2006; Chodosh et al., 2007; Rosenberg et 
al., 2006). It has been estimated that there are 70 percent more individuals with cognitive 
impairment than there are persons with dementia (Plassman et al., 2008). Artero and colleagues 
(2006) outlined the development of new criteria to identify those with cognitive deficits (not 
limited to memory) that do not meet dementia diagnostic criteria, and emphasized that such 
conditions could be associated with “early and subtle changes” that could potentially lead to 
more serious conditions. With the aim of identifying Veterans who potentially fall in this 
category, subtypes of dementias and additional ICD-9 code diagnoses primarily characterized by 
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memory and cognitive impairment (referred to as CIND) were included in this study (e.g., 
310.89 Mild memory disturbance, 331.83 Mild cognitive impairment, 294.90 Cognitive Disorder 
NOS, 294.80 Dementia NOS, and 780.83 Memory loss; see Appendix A).  
In the U.S., the onset of MDD typically occurs as individuals enter puberty and tends to 
peak in their 20’s (APA, 2013). Moreover, due to the growing incidence of MDD in individuals 
from young adulthood to middle age, as well as the variable nature of depression onset, studying 
the role of early-life to mid-life depression onset in predicting dementia and other forms of 
cognitive impairment is advantageous (Byers & Yaffe, 2011). Hence, Veterans who were first 
diagnosed with MDD any time before age 55 were considered for this study. Likewise, Veterans 
first diagnosed with PTSD prior to age 55 were also considered to examine the predictive value 
of having a PTSD history.  
Veterans diagnosed with MDD or PTSD at age ≥ 55 were excluded from the present 
study. The existing literature provides evidence that late-life depression may be a prodrome of 
dementia rather than a risk factor (Barnes et al., 2012; Byers & Yaffe, 2011; Geerlings et al., 
2008). However, scholars indicate that the duration of the prodromal phase of dementia is 
unclear (Wilson et al., 2008). In their study, Wilson and colleagues (2008) examined depression 
as a prodrome to dementia in terms of three to four years before the onset of Mild Cognitive 
Impairment (MCI). The rationale for this was to ensure as much as possible that they assessed 
depressive symptoms prior to the onset of dementia, and measuring symptoms years before MCI 
reduced the risk of missing prodromal symptoms that may begin earlier than expected.  
Similarly, Qureshi et al. (2010) found that for Veterans with an average age of 61, those 
who met criteria for PTSD had twice the incidence and prevalence of dementia compared to 
Veterans who did not have PTSD. The researchers stated that PTSD could possibly be “an early 
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marker of dementia” (Qureshi et al., 2010, p. 1632). To ensure a minimum of a one year gap 
between the first MDD or PTSD diagnosis and dementia/CIND diagnosis, and also to gather data 
on varying forms of cognitive impairment before the typical onset of dementia (i.e., 60 years of 
age), Veterans diagnosed with MDD or PTSD at age ≥ 55 and/or diagnosed with dementia/CIND 
at age ≤ 55 were omitted from the final sample.  
The strong association between MDD and PTSD was an important consideration when 
evaluating inclusion and exclusion criteria for this study (Yaffe et al., 2010). It is important to 
note that Veterans diagnosed with both MDD and PTSD were omitted in efforts to examine the 
role of each condition exclusively. To meet criteria, a Veteran could have only been diagnosed 
with one or the other at age < 55. Further, Veterans diagnosed with any other mental health 
conditions (ICD-9 codes 290.00 to 319.00) except those specified for each group in Appendix B 
were not included in this study.  
Younger Veterans (circa 25 years of age) are known to be at a greater risk for PTSD than 
older Veterans (Seal et al., 2009). Many of these younger Veterans are involved in Operation 
Enduring Freedom/Operation Iraqi Freedom (OIF/OEF) and are an important group to target for 
PTSD treatment; in 2007, approximately 300,000 OEF/OIF Veterans were diagnosed with PTSD 
or depression (Qureshi et al., 2010). Studying how early- or mid-life PTSD, as well as 
depression, may influence dementia and CINDs later in life will provide findings that may aid in 
the treatment of younger Veterans, particularly with regard to MDD/PTSD treatment as a 
preventative treatment of dementia and related conditions.  
A Priori Statistical Power Analysis 
G*Power was utilized to compute an a priori statistical power analysis for sample size 
estimation before data was extracted through VINCI. The power analysis indicated a sample size 
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of 1,680 would be adequate to detect small to medium changes in the logistic regression model 
(OR = 2.25; 1 – β = .95; p < .05). In logistic regression, the best effect size measure has been 
identified as the odds ratio (OR) by many researchers (Faul, Erdfelder, Buchner, & Albert-
Georg, 2009; Field, 2013; Rosenthal, 1996). The OR has become particularly important when 
studying diseases with lower than a 10 percent prevalence rate (Chen, Cohen, & Chen, 2010), 
making it an appropriate measure of effect size for this study with the prevalence rate of 
dementia/CIND in the Veteran and general population being approximately 7 percent (Dotson et 
al., 2010; Plassman et al., 2007; Veitch et al., 2013; Yaffe et al., 2010). Chen et al. (2010) 
calculated equivalent OR values for Cohen’s d (Cohen, 1992) across studies where disease rates 
were low (less than 10 percent), with Cohen’s interpretation recommendations of d = .2 (small), 
.5 (medium), and .8 (large) considered within the context of the study. For a disease with a 
prevalence rate of 7 percent, Chen et al. (2010) presented odds ratio values with equivalent 
Cohen’s d values as the following: 1.1 to 1.4 equivalent to d < 0.20 (“weak association”); 1.5 to 
4.0 with d > 0.20 and d < 0.80 (“moderate association”); and 5.0 to 30.0 with d > 0.80 ("strong 
association"; see Tables 1 and 2 on pp. 862-863 for more information).  
Participants were divided into two racial categories, Black and White, due to the 
demographic data of the U.S. Veteran population. The U.S. Census Bureau (2012) reported that 
the Veteran population comprised of 11 percent Black and 80 percent White individuals, leaving 
9 percent for other minority groups. Grouping all the minority subgroups into one group may 
have been the only way to obtain adequate statistical power for purposes of this study, as data 
with a sufficient number of participants in each minority subgroup was not available. However, 
due to the variability between, as well as within, specific minority subgroups (Oh, Galanter, 
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Thakur, Pino-Yanes, Barcelo, et al., 2015; Pinquart & Sorensen, 2005), only Black and White 
individuals were included in this study.  
Sampling Procedures 
Initial sample. The initial cohort consisted of 13,812,853 Veteran subjects whose records 
were obtained through VINCI (U.S. Department of Veterans Affairs, 2014). From this cohort, 
7,723,634 subjects were omitted due to possible invalid identifiers and/or for not meeting 
inclusion criteria related to sex (i.e., male or female) and race (i.e., Black or White). Five 
subjects were removed from the sample due to having multiple sex identifiers (e.g., identifying 
as both male and female), and 20,941 records were omitted for having multiple race identifiers 
(e.g., identifying as both Black and White). This resulted in a final sample of 6,068,273 subjects.  
Creation of three cohort tables. From the sample of 6,068,273, subjects meeting criteria 
for MDD, PTSD, and no mental health history were selected and a separate table was created for 
each cohort in Microsoft SQL Server. Cohort 1 included 115,245 subjects meeting criteria for 
MDD, as outlined in Appendix B. Cohort 2 consisted of 146,688 subjects meeting criteria for 
PTSD, also listed in Appendix B. Cohort 3 consisted of 861,905 subjects without any mental 
health diagnosis (ICD-9 codes 290 to 319) prior to age 55. Then, subjects with dementia/CIND 
diagnosis (listed in Appendix A) prior to age 56 were removed from each cohort. Thus, the final 
sample for Cohort 1 consisted of 55,076 subjects after exclusion of 60,169 with dementia/CIND 
prior to age 56. The final sample for Cohort 2 included 84,853 subjects after exclusion of 61,835 
with dementia/CIND prior to age 56. Cohort 3 had a final sample of 620,403 after exclusion of 
241,502 subjects with dementia/CIND prior to age 56.  
Twelve subgroups. From each of the three final cohort tables, four separate tables were 
created for Veterans with distinct demographic backgrounds (resulting in a total of 12 tables): (1) 
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Black/female, (2) White/female, (3) Black/male, and (4) White/male. Then, for the final sample 
of this study, an equal number of Veterans were randomly selected from each of these 12 tables 
in Microsoft SQL Server using standardized SQL query language statements of random selection 
of information from databases. An a priori power analysis was previously employed for sample 
size estimation also considering that most U.S. Veterans aged ≥ 60 are White and male (U.S. 
Census Bureau, 2012), thus it was possible that there would not be enough data for female 
Veterans aged ≥ 60 who self-identified as Black. Further, considering the low prevalence rates of 
dementia (5 to 8 percent), a larger sample than specified by the power analysis (N = 1,680) was 
intended to be selected [if available] to increase the likelihood of detecting varying levels of 
predictive ability of the IVs. The smallest of the 12 tables (Black/female group in Cohort 2 – 
PTSD) consisted of 495 Veterans’ records, thus, a total of 400 subjects from each of the 12 
tables were randomly selected, resulting in a total sample size 4,800 Veteran subjects.  
Initially, using equal sample sizes was implemented in research studies to make casual 
inferences. Recently, scholars have used this method for other objectives, such as conducting 
observational epidemiological studies (Rubin, 1973). Many have attempted to achieve equal 
group sizes particularly when examining topics such as racial health disparities, sex, 
socioeconomic status, etc. (Dore, Waldstein, Evans, & Zonderman, 2015; Polednak, 2001). 
Accordingly, given that demographic variables such as race were examined in this study, an 
equal number of Veterans per subgroup was intended to reduce bias (Rubin, 1973). A flowchart 
of the sampling procedures and numbers of subjects at each step can be found in Figure 1.  
Participants   
The sample for this study consisted of 4,800 Veterans aged ≥ 60 years. The participants 
were randomly selected from cohort tables for MDD, PTSD, and no mental health history (i.e., 
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None) in order to create 12 separate subgroups based on demographic characteristics (see Table 
1). Baseline age, in years, was calculated for all subjects on March of 2016. Participant (N = 
4,800) age ranged from 61 to 71 (M = 64.57, SD = 2.58), with age rounded to the nearest year. 
The 12 subgroups included an equal number of subjects in each demographic group (n = 2,400 
per each), and the age range (rounded to the nearest year) for Veterans in each subgroup was also 
61 to 71 years. The mean (with standard deviation) age, in years, for women (n = 2,400) and men 
(n = 2,400) were 63.94 (SD = 2.41) and 65.20 (SD = 2.60), respectively. The mean (with 
standard deviation) ages, in years, for Black (n = 2,400) and White (n = 2,400) Veterans were 
64.31 (SD = 2.53) and 64.83 (SD = 2.61). Marital status (with mean age, in years, and standard 
deviations) was reported as 38.5% married (n = 1,853; M = 64.81, SD = 2.67), 39.5% divorced 
or separated (n = 1,896; M = 64.48, SD = 2.52), 14.4% single or never married (n = 693; M = 
64.17, SD = 2.48), widowed (n = 306; M = 64.54, SD = 2.57), and 1.1% unknown or missing (n 
= 52; M = 64.75, SD = 2.15).  
Cohort 1 (C1): History of MDD before age 55. The age range for subjects in C1 (n = 
1,600) ranged from 61 to 71 (M = 64.05, SD = 2.39). C1 consisted of subgroups 1 to 4, with 400 
(8.3% of N) in each. Age during the first MDD diagnosis ranged from 45 to 54 (M = 50.80, SD = 
2.47), and the number of years since the first MDD diagnosis ranged from 7 to 17 (M = 13.25, 
SD = 2.39). Marital status of subjects in C1 was reported as 32.7% (n = 523) married, 44.6% (n = 
712) divorced or separated, 15.1% (n = 241) single or never married, and 7.6% (n = 122) 
widowed.   
Cohort 2 (C2): History of PTSD before age 55. The age range for subjects in C2 (n = 
1,600) ranged from 61 to 71 (M = 64.94, SD = 2.59). C2 consisted of subgroups 5 to 8, with 400 
(8.3% of N) in each. Age during the first PTSD diagnosis also ranged from 45 to 54 (M = 51.34, 
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SD = 2.29), and the number of years since the first PTSD diagnosis ranged from 7 to 17 (M = 
13.60, SD = 2.46). Marital status of subjects in C2 was reported as 40.1% (n = 639) married, 
39.9% (n = 636) divorced or separated, 14.4% (n = 230) single or never married, and 5.6% (n = 
90) widowed.   
Cohort 3 (C3): No mental health diagnosis before age 55. The age range for subjects 
in C3 (n = 1,600) ranged from 61 to 71 (M = 64.72, SD = 2.68). C3 consisted of subgroups 9 to 
12, with 400 (8.3% of N) in each. Marital status of subjects in C3 was reported as 44.4% (n = 
691) married, 35.2% (n = 548) divorced or separated, 14.3% (n = 222) single or never married, 
and 6.0% (n = 94) widowed.    
Additional information on participant characteristics are presented in Table 2. 
Differences between participants based on cohorts, subgroups, and other characteristics are 
reported in the Results section below. 
Data Analysis  
The data for this study were analyzed in three sequential steps, beginning with the a priori 
statistical power analysis. The first dataset included Veterans diagnosed with dementia/CIND at 
age ≥ 60 years, and the second dataset included Veterans diagnosed at age ≥ 56 years. The 
findings from the second dataset will be the main focus of this study. G*Power, a statistical 
power analysis program, Microsoft Excel, and the Statistical Package for the Social Sciences 
(SPSS) were used to examine the data. 
First analysis: Veterans diagnosed with dementia/CIND at age ≥ 60. Descriptive 
analyses and crosstabulations with chi-square were conducted to gather demographic and 
baseline characteristics of the sample. Chi-square (χ2) and independent samples t-tests were 
employed to examine differences between groups. The Pearson product moment correlation 
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coefficient (r) was used to determine correlations between the outcome and predictor variables. 
The variance inflation factor (VIF) value, tolerance value, and variance proportions were 
analyzed to determine if there was collinearity among the study variables. Linearity of the logit 
and potentially influential outliers (using Cook's distance and Mahalanobis distance) were also 
inspected to discover if the assumptions of logistic regression were met. 
The primary analysis consisted of binary logistic regression to examine preexisting MDD 
and PTSD as predictors of dementia/CIND. Additional covariates that were examined for their 
predictive utility included race, sex, and their interactions with MDD and PTSD. Other risk 
factors of dementia/CIND identified in the literature were also studied, including subjects’ 
current age and approximate duration of MDD/PTSD symptoms (Byers & Yaffe, 2011; Kaup et 
al., 2016). The first logistic regression analysis included the examination of MDD, PTSD, race, 
and sex as predictors of dementia/CIND diagnosed in Veterans aged ≥ 60 years. Sampling 
procedures for this initial dataset involved removing subjects from each Cohort who were 
diagnosed with dementia/CIND prior to age 60, rather than age 56 (as described in the Methods 
– Sampling Procedures section).  
There were 210 subjects in the initial sample diagnosed with dementia/CIND at age ≥ 60. 
Although the overall logistic regression model was statistically significant, the predictive utility 
of individual variables were weak. Based on the Nagelkerke R2 value of .14, which resembles the 
R2 in linear regression, the overall model accounted for a very small amount variance in the DV. 
This statistic should, however, be interpreted with caution, as it is considered a pseudo R2 value.  
The model was able to correctly classify 45.2% of the dementia/CIND cases, suggesting a less 
than 50-50 chance of accurately identifying persons with dementia/CIND.   
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Second analysis: Veterans diagnosed with dementia/CIND at age ≥ 56. Given that the 
results from the first set of analyses were largely insignificant, data obtained through VINCI 
were further analyzed for variables that could potentially have an impact on dementia/CIND. A 
second dataset was created, which included Veterans diagnosed with dementia/CIND at age ≥ 
56, rather than age ≥ 60. This ensured that there would remain a one year gap between 
MDD/PTSD and potential dementia/CIND, which would be important to examine predictive 
utility of the disorders. It also included a total of 336 subjects with positive dementia/CIND 
status, which was 126 more subjects with dementia/CIND within a four year duration (from ages 
56 to 59) who were not included in the first analysis. This dataset was also extracted from the 
same three cohorts created from the initial sample of 6,068,273. Information about the three 
tables for Cohorts 1, 2, and 3 are highlighted in gray in Figure 1.  
The finding that difficulties with cognitive functioning were present in this Veteran 
population earlier than the typical age of onset of dementia in the general population (age ≥ 60) 
is not surprising, considering that many scholars have reported Veterans are at an increased risk 
of senescence-associated medical conditions at an earlier age (Lohr et al., 2015; Sibener et al., 
2014). Therefore, the rationale for the second set of analyses was the growing need to study an 
increasing population of aging Veterans who are at a higher risk for accelerated cognitive decline 
that potentially onsets earlier than observed in the general population (Sibener et al., 2014).  
Descriptive data, group differences, and correlations among all variables were analyzed 
with this second dataset of Veterans diagnosed with dementia/CIND after age 55. Variables that 
were significant in the bivariate analyses or relevant to the hypothesis of this study were then 
analyzed using logistic regression, which consisted of dementia/CIND as the dependent variable 
(DV), and MDD history, PTSD history, race, and sex as the predictor variables. It should be 
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noted that because age has been well-established as a risk factor of dementia/CIND (Chen, Lin, 
& Chen, 2009; World Health Organization, 2015), it was adjusted for in all the logistic 
regression models unless otherwise stated. In addition, scholars have found that the type of 
depressive symptoms may also influence the amount of risk a person has of developing dementia 
and related conditions. Specifically, depressive symptoms that were more severe and continued 
to increase were predictive of the highest level of dementia risk (Kaup et al., 2016). Accordingly, 
in this study, the number of years since the first MDD/PTSD diagnosis were calculated to 
discover the impact, if any, the chronicity or duration of MDD/PTSD had on the development of 
dementia/CIND. The amount of time since the first MDD/PTSD diagnosis was used to measure 
chronicity because symptoms of both conditions are known to typically endure throughout a 
person’s life, sometimes despite efforts to obtain treatment or occurrence of remission periods 
(Kaup et al., 2016; Veitch et al., 2013).  
After the bivariate analyses, binary logistic regression was employed to test the predictive 
utility of MDD and PTSD, with dementia/CIND diagnosis as the dichotomous DV. The two 
conditions were examined separately, and then together. These set of analyses were repeated a 
second time adjusting for the influence of CurrentAge. The remaining logistic regression 
analyses involved three separate models, all with dementia/CIND diagnosis as the DV. The steps 
taken during the analyses are denoted with superscript alphabetical letters, such as Model 1a, 1b, 
and 1c, and are based on recommended model building strategies from the literature. Three 
common model building strategies used for logistic regression include direct, hierarchical, and 
stepwise methods (Peng, Lee, & Ingersoll, 2002). The direct model building approach is 
typically employed when a priori hypotheses are lacking, whereas the hierarchical method is 
suitable for clarifying patterns of casual relationships between predictor and outcome variables 
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(Stoltzfus, 2011). Further, although stepwise regression techniques have been considered 
controversial by some researchers, they have nonetheless been worthwhile for preliminary 
screening and hypothesis testing (Reed & Wu, 2013; Stoltzfus, 2011). Based on the current 
knowledgebase of prevalence rates and predictors of dementia/CIND among the general and 
Veteran populations, hierarchical and stepwise logistic regression methods were selected in this 
study for the logistic regression analyses.  
 Age, MDD, and recently PTSD, are well-established risk factors of dementia and CINDs 
(Byers et al., 2012; Qureshi et al., 2010; Yaffe et al., 2010). In contrast, data on race and sex as 
risk factors varies and additional research is necessary for clarification (Akincigil et al., 2012; 
Breslau, 2009; Katz et al., 2012; Plassman et al., 2008; Plassman et al., 2007). Therefore, each of 
the three models were originally built using hierarchical logistic regression to clarify the role of 
race and sex in predicting dementia/CIND, and also to determine whether the addition of new 
interaction variables added to the predictive validity of the model (Reed & Wu, 2013).  
Then, backward stepwise methods were employed in the last step of each model to 
further inspect the impact of individual variables, particularly the interactions between 
demographic variables and psychiatric history or chronicity. The stepwise method proved 
valuable for this purpose, especially due to the lack of consistent evidence in the literature about 
demographic variables as risk factors of dementia/CIND (Katz et al., 2012; Reed & Wu, 2013; 
Stoltzfus, 2011). Research on the chronicity of MDD and PTSD as risk factors is also limited, 
and most existing studies have considered depressive symptoms only at one point in time 
(Barnes et al., 2012; Kaup et al., 2016). In this study, Models 2duration and 3duration were built with 
similar methods as those implemented for Model 2 and 3, respectively. However, MDDduration 
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and PTSDduration were the main predictor variables under investigation in Models 2duration and 
3duration, rather than MDD and PTSD history.   
Hierarchical logistic regression was used for Model 1a, which included MDD history, 
PTSD history, sex, and race as the predictors, while adjusting for current age. Age was entered in 
the first block, MDD and PTSD into the second block, and race and sex into the third block. In 
the second step (Model 1b), the interactions between sex with MDD (Sex*MDD) and PTSD 
(Sex*PTSD), and the interactions between race with MDD (Race*MDD) and PTSD 
(Race*PTSD) were included in the subsequent block.  
Finally, all nine variables from Model 1b were entered into one block using the backward 
stepwise method in Model 1c. Researchers have indicated that the backward, versus the forward, 
stepwise method is preferred when conducting exploratory analyses for logistic regression, 
because it begins with all predictors in the model and removes  those based on their impact on 
the -2LL value (Reed & Wu, 2013). If the -2LL value of the model significantly decreased after 
a certain variable was initially removed, then that variable was kept in the model. Provided that 
the existing findings on relevant demographic predictors of dementia/CIND are inconsistent, and 
that the individual predictors were largely significant in Model 1a, yet insignificant in Model 1b, 
the backward stepwise method was beneficial in Model 1c for identifying if any of the new 
interaction variables were stronger than others in predicting dementia/CIND (Reed & Wu, 2013).    
Sex, MDD, PTSD, and the interactions between sex with MDD (sex*MDD) and sex with 
PTSD (sex*PTSD), while adjusting for current age, were examined in Model 2. In Model 2a, 
MDD and PTSD were entered into one block, and sex was entered in the following block. Then, 
the two interaction variables were added to the model in the subsequent block (Model 2b). The 
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third step, Model 2c, entailed entering all five variables in one block using the backward stepwise 
method.  
The same methods were implemented for Model 3, however, race was the demographic 
variable under investigation. An additional analysis was conducted for both Models 2 and 3 that 
involved MDDduration and PTSDduration as the main predictors (rather than MDD and PTSD 
history) using the same procedures. The final step of these analyses [of MDD/PTSD duration] 
will be reported in the Results – Logistic Regression Analysis section below and presented in 
corresponding tables. These models are denoted with “duration” written in superscript format 
after the model number (e.g., Model 2duration and Model 3duration).  
Classification cutoff and Model Validity. It should be noted that a classification cutoff 
of .07 was used for the logistic regression analysis based on the rate of positive dementia/CIND 
cases in the current study sample (7 percent). Researchers estimated prevalence rates for 
Veterans in similar age groups to be approximately 7.3 percent (Wray et al., 2014). In addition to 
disease prevalence rates, sensitivity and specificity should be considered when determining the 
optimal cutoff criterion (Hanley & McNeil, 1982). Accordingly, a receiver operating 
characteristic (ROC) curve analysis was conducted and the area under the curve (AUC) was 
analyzed to determine the optimal classification cutoff for the analysis. 
The ROC curve is one of the most common methods for inspecting the discrimination 
ability of a model or test, and the AUROC (area under the ROC curve) has been described as the 
best quantitative index to describe the curve (Hanley & McNeil, 1982; Kumar & Indrayan, 
2011). The AUROC denotes “the probability of correctly identifying” positive and negative 
cases (Hanley & McNeil, 1982, p. 29), and it continues to be used frequently, especially in 
biomedical research (Dalrymple-Alford et al., 2010; Dujardin et al., 2010). The ROC curve 
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shows the “full picture of trade-off between the sensitivity and specificity across a series of 
cutoff points” (Kumar & Indrayan, 2011, p. 277).  
For this study, the ROC curve indicated the probability that individuals who had 
dementia/CIND were correctly being classified as having the condition, and individuals who did 
not have dementia/CIND were correctly being identified as not having been diagnosed with 
dementia/CIND. The classification cutoff of .07 was applied based on the predicted probability 
values obtained from a logistic regression analysis with MDD, PTSD, race, and sex as the 
predictors, and then used for the ROC curve analysis. The cutoff was chosen because it 
maximized sensitivity (.631) and specificity (.490). After conducting the logistic regression 
analyses, the AUROC curve analysis was conducted again to determine the discrimination 
validity of Models 1, 2, and 3.  
Results 
Demographic Characteristics 
Descriptive statistics of Veterans’ demographic characteristics were calculated separately 
for all groups, including those with and without a dementia/CIND diagnosis (see Table 2). This 
retrospective study consisted of a total sample of 4,800 Veteran subject (M = 64.57, SD = 2.58), 
with 336 subjects having a dementia/CIND diagnosis at age > 55. The mean age (with standard 
deviation) during which subjects (n = 336) were first diagnosed with dementia/CIND was 60.83 
(SD = 3.18). The prevalence rate of positive dementia/CIND cases (7 percent) was consistent 
with the rates reported in the existing literature among the general and Veteran population 
(Hebert et al., 2013; Lohr et al., 2015; Prince et al., 2013). 
Current age. There was a significant difference between the current age of Veterans 
diagnosed with dementia/CIND (n = 336; M = 65.64, SD = 2.50) and those without 
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dementia/CIND (n = 4,464; M = 64.49, SD = 2.57), t(4798) = -7.95, p < .000, with Veterans 
diagnosed with dementia/CIND being older.  
History of MDD (Cohort 1). Of the Veterans with a history of MDD prior to age 55 (n 
= 1,600), 124 (7.8%) were diagnosed with dementia/CIND. These individuals made up 36.9% of 
the sample with dementia/CIND (n = 336), and 2.6% of the total sample (N = 4,800). The 
percentage of Veterans diagnosed with dementia/CIND after age 55 did not differ based on 
history of MDD, χ2(1, N = 4800) = 2.07, p = .150. The mean chronicity of MDD, in years, was 
13.76 (SD = 2.24) in positive cases of dementia/CIND, and 13.21 (SD = 2.40) in cases without 
dementia/CIND, which were found to be significantly different, t(1598) = -2.48, p = .013. The 
average number of years between the first MDD diagnosis and first dementia/CIND diagnosis 
was 8.95 (SD = 3.40). Subjects with dementia/CIND were first diagnosed with MDD at a 
slightly older age (M = 51.26, SD = 2.30) compared to the age that subjects without 
dementia/CIND were first diagnosed with MDD (M = 50.76, SD = 2.48).  
History of PTSD (Cohort 2). Among Veterans with a history of PTSD prior to age 55 (n 
= 1,600), 131 (8.2%) were diagnosed with dementia/CIND, which was 39.0% of the positive 
dementia/CIND cases (n = 336), and 2.7% of the total sample (N = 4,800). The percentage of 
Veterans diagnosed with dementia/CIND after age 55 were significantly different based on 
history of PTSD, χ2(1, N = 4800) = 5.20, p = .023. Likewise, the mean chronicity of PTSD, in 
years, was determined to be statistically different among Veterans with (M = 14.28, SD = 2.26) 
and without (M = 13.54, SD = 2.47) dementia/CIND, t(159) = -3.58 = p < .000. Levene’s test 
indicated unequal variances (F = 6.76, p = .009), thus degrees of freedom were adjusted from 
1598 to 159. The average number of years between first PTSD diagnosis and first 
dementia/CIND diagnosis was 9.52 (SD = 3.29). Subjects with dementia/CIND were first 
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diagnosed with PTSD at a slightly older age (M = 51.70, SD = 1.89) compared to the age that 
subjects without dementia/CIND were first diagnosed with PTSD (M = 51.31, SD = 2.32). 
Sex: Female or male. Veteran subjects diagnosed with dementia/CIND differed 
significantly by sex, χ2(1, N = 4800) = 17.52, p < .000. There were 131 (5.5%) women and 205 
(8.5%) men diagnosed with dementia/CIND. Among the positive dementia/CIND cases (n = 
336), 39% were women and 61% were men.   
Race: White or Black. The proportion of subjects with dementia/CIND also differed 
significantly by race, χ2(1, N = 4800) = 5.12, p = .024. There were 148 (6.2%) Black individuals 
and 188 (7.8%) White individuals diagnosed with dementia/CIND. Among the positive 
dementia/CIND cases (n = 336), 44% self-identified as Black whereas 56% of them self-
identified as White.   
Marital status: Single/unmarried, married, divorced/separated, and widowed. The 
percentage of individuals with dementia/CIND did not differ significantly by marital status, χ2(3, 
N = 4748) = 3.98, p = .263. There were 58 (8.4%) single/unmarried, 117 (6.3%) married, 136 
(7.2%) divorced/separated, and 25 (8.2%) widowed subjects diagnosed with dementia/CIND. 
Among the 336 individuals with dementia/CIND, 17.3% were reported as single/unmarried, 
34.8% as married, 40.5% as divorced/separated, and 7.4% as widowed. It should be noted that 
there were 52 (1.1% of N) cases with missing or unknown marital status, and these were coded 
as missing in the SPSS dataset. Additional information on demographic characteristics can be 
found in Table 2, including frequency (percentage), mean (standard deviation), and chi-square or 






Frequency (with percentage) and chi-square values were calculated for each of the 12 
subgroups (Table 3). Each subgroup (n = 400) was compared to the rest of the sample (n = 4,400 
in the 11 other subgroups). The percentage of subjects with and without dementia/CIND were 
significantly different for 2 of the 12 subgroups, one of which was the C2G8 (Cohort 2, Group 8) 
White/Male subgroup, χ2(1, N = 4800) = 20.28, p < .000. Among the 400 men in C2G8, 50 
(12.5%) subjects had dementia/CIND and 350 (87.5%) did not. Veterans in C2G8 had the 
highest rate of dementia/CIND compared to the rest of the sample, which suggested that among 
Veterans aged ≥ 60 years, White male Veterans with a history of PTSD were at greater risk 
compared to other Veterans (e.g., female Veterans, Veterans who self-identified as Black, and/or 
other White male Veterans who did not have a history of PTSD).  
Subjects with and without dementia/CIND also significantly differed based on the C3G9 
(Cohort 3, Group 9) Black/Female subgroup, χ2(1, N = 4800) = 12.11, p = .001. There were 11 
(2.8%) Veterans in C3G9 with dementia/CIND, which was the lowest rate found compared to the 
rest of the sample. This finding indicated that Black female Veterans without a psychiatric 
history prior to age 55 had lower chances of getting dementia/CIND when compared to other 
Veterans (e.g., male Veterans, White Veterans, and/or other Black female Veterans with a 
psychiatric history prior to age 55). 
Although the chi-square tests did not reveal additional significant associations, patterns in 
prevalence rates of dementia/CIND were nonetheless observed across subgroups. For example, 
the three White/Male groups had the highest number of dementia/CIND cases (n = 114) when 
compared to the three Black/Male groups (n = 91), then White/Female groups (n = 74), and 
Black/Female groups (n = 57). Greater dementia/CIND rates were consistently observed for men 
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compared to women across all three cohorts. With the exception of C1 (history of MDD), White 
men and women had higher rates compared to Black men and women, respectively. Importantly, 
the Black/Male group (n = 36, 9.0%) with a history of MDD (C1) had greater rates of 
dementia/CIND compared to the White/Male group (n = 34, 8.5%) in C1. The Black/Female and 
White/Female groups in C1 had the same rate of dementia/CIND (n = 27, 6.8% for both racial 
groups).  
Further, the rate of dementia/CIND for White male Veterans without a psychiatric history 
(C3G12) was greater than the rate for both Black and White female Veterans with a history of 
MDD or PTSD. However, when a history of MDD was considered, rates for both Black and 
White female Veterans were 6.8%, which is not significantly lower than the rate for (7.5%) 
White male Veterans without a psychiatric history. When comparing the rates of subgroups to 
the overall dementia/CIND prevalence rate found in this study (7%), White male Veterans across 
all Cohorts had higher rates, and Black male Veterans had higher rates if a history of MDD or 
PTSD was present. Interestingly, all six groups consisting of female Veterans had lower rates 
than 7%, except that in some instances, rates were only slightly lower (e.g., 6.8%). It is important 
to note that although White Veteran groups had higher rates than Black Veterans in Cohorts 2 
and 3, Black male Veterans appeared to be at an increased risk if a history of MDD was present 
(Cohort 1). The number (with percentages) of positive and negative dementia/CIND cases within 
each of the 12 groups are reported in Table 3 and are presented in a bar graph format in Figure 2.  
Relationships among Predictor and Outcome Variables 
Results from the chi-square analyses and independent samples t-tests revealed 
statistically significant differences between Veterans with and without dementia/CIND based on 
the following variables (with descriptions): (1) CurrentAge (participants’ current age, in years), 
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(2) MDDduration (number of years since the first MDD diagnosis), (3) PTSD (history of PTSD 
prior to age 55) as a dichotomous predictor coded as “0” (no PTSD history) and “1” (with PTSD 
history), (4) PTSDduration (number of years since the first PTSD diagnosis), (5) sex coded as 
“0” (male) or “1” (female), and (6) race coded as “0” (White) or “1” (Black). These six variables 
were selected for analysis in the logistic regression models. 
Although MDD history was not found to be statistically significant, it was nonetheless 
included in the logistic regression models based on the study hypothesis, and also the robust 
evidence that exists in the literature identifying it as a significant risk factor of dementia and 
other forms of cognitive impairment (Barnes et al., 2012; Byers et al., 2012; Byers & Yaffe, 
2011). MDD as a predictor variable was coded in the same manner as PTSD, with “0” (no MDD 
history prior to age 55) and “1” (with MDD history prior to age 55). The dichotomous outcome 
variable, dementia/CIND diagnosed after age 55, was coded as “0” (without dementia/CIND) 
and “1” (with dementia/CIND). The predictor variables included in the logistic regression 
analyses and their frequency (χ2) or mean (t statistic) values as a function of dementia/CIND are 
presented in Table 4. 
Pearson product moment correlation coefficients (r) were also calculated for predictor 
and outcome variables (see Table 5). The coefficients for this study were interpreted as 
recommended by Cohen (1992)—an r value of .10 indicates a small effect (1 percent of the total 
variance), .30 indicates a medium effect (9 percent of the total variance), and .50 and above 
indicates a large effect (25 percent of the total variance). Contrary to the existing literature, the 
relationship between dementia/CIND and history of MDD was not statistically significant in the 
current study, r(4798) = .021, p = .150. However, although small, the correlation between 
dementia/CIND and MDDduration was statistically significant, r(1598) = .06, p < .05.  
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The relationship between CurrentAge and the other variables were all statistically 
significant (p < .01). CurrentAge was strongly correlated with MDDduration, r(1598) = .465, p < 
.01, and PTSDduration, r(1598) = .590, p < .01, which is to be expected because the duration of 
psychiatric symptoms depends on an individual’s age. CurrentAge had smaller, yet significant 
positive relationships with dementia/CIND, r(4798) = .114, p < .01, and PTSD history, r(4798) 
= .101, p < .01. In contrast, it was negatively related to MDD history, r(4798) = -.142, p < .01), 
sex, r(4798) = -.244, p < .01, and race, r(4798) = -.100, p < .01.  
Although MDD was not significantly related to the outcome variable, it had a strong 
negative correlation with PTSD, r(4798) = -.500, p < .01. PTSD, r(4798) = .033, p < .05, and 
PTSDduration, r(1598) = .083, p < .01, were both significantly related to dementia/CIND, 
though both of their effects were small. Sex, r(4798) = -.060, p < .01, and race, r(4798) = -.033, 
p < .05, were both negatively correlated with dementia/CIND, potentially suggesting that female 
Veterans (female was coded as “1” and male as “0”), and Black Veterans (Black was coded as 
“1” and White as “0”), were at lower risk of developing dementia/CIND when compared to male 
Veterans, and White Veterans, respectively.  
Neither sex nor race were correlated with MDD, r(4798) = .000, p = 1.00, or PTSD, 
r(4798) = .000, p = 1.00. In addition, sex did not have a significant relationship with 
MDDduration, r(1598) = -.021, p = .397. Race, however, was negatively correlated with 
MDDduration, and this effect was statistically significant, r(1598) = -.104, p < .000. Both 
demographic variables were negatively related to PTSDduration, with a statistically significant 
moderate effect for sex, r(1598) = -.292, p < .01) and a statistically significant small effect for 
race, r(1598) = -.060, p < .05. The demographic variables were not correlated with each other, 
r(4798) = .000, p = 1.00.  
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Although the r coefficients indicated generally small effects and weak relationships 
between the variables, there were nonetheless many statistically significant correlations between 
the study variables. Moreover, many of the odds ratio (OR) values interpreted as effect size in the 
logistic regression analysis (which will be discussed in the next section) were significant and 
ranged from having small to medium effect sizes (based on Chen et al., 2010; Cohen, 1992).  
Logistic Regression Analysis 
Assumptions. Veterans’ data were first examined to ensure the assumptions of logistic 
regression were met. The assumptions, which are similar to those of linear regression, include 
absence of multicollinearity, independence of errors, linearity of the logit (for continuous 
variables), and lack of strongly influential outliers (Mertler & Vannatta, 2013; Stoltzfus, 2011).  
Absence of multicollinearity. Employing a linear regression analysis in SPSS with the 
predictor variables, the variance inflation factor (VIF), tolerance values, and variance proportions 
were inspected for potential multicollinearity among the variables. Collinearity occurs when two 
variables are strongly correlated, whereas multicollinearity occurs when more than two predictor 
variables are intercorrelated (Field, 2013). Generally, an r of .80 or higher is suggestive of two 
predictors measuring similar occurrences (Field, 2013; Mertler & Vannatta, 2013).  
The strongest significant correlation among the variables in this study was r = -.500 
between MDD and PTSD, indicating that about 25 percent of the variance in the predictors were 
related (Cohen, 1992). Additionally, the variance proportions of MDD, PTSD, and CurrentAge 
were .41, .42, and .96, respectively, on condition 5, which had the smallest eigenvalue (see Table 
6). Researchers have stated that if multiple variables have high variance proportions on the same 
small eigenvalue (typically at the bottom of a Collinearity Diagnostics table), it is possible that 
dependency among the variables may be a problem (Field, 2013). However, the tolerance values 
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for all variables were greater than .1, VIF values were all less than 10, and the mean of VIF 
values was 2.55, all of which researchers have recognized as indicators that multicollinearity is 
likely not a significant problem for the model (Field, 2013; Mertler & Vannatta, 2013; Stoltzfus, 
2011). 
Linearity of the logit. The continuous variables included in the logistic regression 
analyses (i.e., CurrentAge, MDDduration, and PTSDduration) were examined to ensure each was 
linearly related to the log of the outcome variable, dementia/CIND diagnosed after age 55 (Field, 
2013). Each variable was interacted with the log of itself, and the resulting interaction variables 
were examined in a logistic regression analysis. The three interaction variables were not 
statistically significant, thus, demonstrating that the main effects did not violate the assumption 
of linearity of the logit.  
Influential outliers. Cook’s distance was used to analyze the overall influence of each 
case in the model. Values greater than 1 indicate there may be a case that is exerting additional 
influence on the model compared to other cases (Cook & Weisberg, 1983). The Cook’s distance 
values for the variables of this study ranged from .000 to .106, which did not suggest a problem.  
The Mahalanobis distance (D2) was also inspected to discover any potential multivariate 
outliers (Mertler & Vannatta, 2013). This statistical procedure determines the distance of a case 
from the centroid (the point created by the means of all the variables) of the remaining cases. The 
distance is calculated as a chi-square (χ2) statistic with degrees of freedom (df) equal to the 
number of variables in the analysis (p. 31). Researchers identify outliers as cases with a D2 value 
greater than the chi-square critical value significant beyond p < .001 (Cousineau & Chartier, 
2015; Mertler & Vannatta, 2013). In this study, there were no cases exceeding χ2(5) = 20.515 at 
p < .001, thus suggesting a lack of outliers.  
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MDD and PTSD. Prior to examining demographic risk factors, binary logistic regression 
analysis was conducted to determine the predictive utility of MDD and PTSD separately, and 
together, with and without the adjusting for CurrentAge. When the model only included MDD, it 
was not statistically significant, χ2(1, N = 4800) = 2.04, p = .153. After adjusting for age, the 
model was significant when compared to a constant only model, χ2(2, N = 4800) = 67.98, p < 
.000. This model correctly predicted 65.8% of positive dementia/CIND cases, and 56.9% of 
cases without dementia/CIND, for an overall classification success rate of 57.5%. 
In accordance with Chen and colleagues’ (2010) recommendations for understanding the 
magnitude of odds ratio (OR) values as approximate equivalents to Cohen’s d (Cohen, 1992), the 
odds ratios of the predictor variables in the logistic regression analyses were interpreted as effect 
size based on the dementia/CIND disease rate of .07. OR values of 1.49 (“weak association”), 
2.62 (“moderate association”), and 4.42 (“strong association”) were recognized as being 
equivalent to Cohen’s d of .2 (small), .5 (medium), and .8 (large), respectively (p. 862).   
 When MDD history and CurrentAge were both included in the model, the risk of 
dementia/CIND increased significantly, OR = 1.38, 95% CI [1.09, 1.75], p .007.  An OR of 1.38 
is indicative of a weak association, with d > 0.13 and d < 0.17. The same methods were then 
employed to examine the predictive utility of a history of PTSD, and interestingly, results for 
PTSD history were in contrast to those found for MDD history. A binomial logistic regression 
model with only PTSD was statistically significant, χ2(1, N = 4800) = 5.08,  p = .024. The odds 
ratio value of PTSD, OR = 1.30, 95% CI [1.04, 1.64], p = .023, was similar to that of MDD, 
suggesting a weak association among the conditions and dementia/CIND. When adjusting for 
age, the model with PTSD was considered statistically significant, χ2(2, N = 4800) = 63.09, p < 
.000, yet PTSD was not independently significant, p = .133. 
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A model with both MDD and PTSD was statistically significant compared to a constant 
only model, χ2(2, N = 4800) = 14.78, p = .001. Further, MDD (b = .46, Wald χ2(1) = 9.50, p = 
.002) and PTSD (b = .51, Wald χ2(1) = 12.40, p < .000) were also both significant in predicting 
dementia/CIND. Notably, Veterans with a history of MDD prior to age 55 experienced one and a 
half times as much increased risk of developing dementia/CIND when PTSD was held constant, 
OR = 1.58, 95% CI [1.18, 2.10]. Moreover, a history of PTSD (when controlling for MDD) 
resulted in almost double the chances of getting dementia/CIND, OR = 1.67, 95% CI [1.27, 
2.25]. This analysis demonstrated that when controlling for the other, both MDD and PTSD had 
moderate associations with dementia/CIND. This model accurately classified 75.9% of 
individuals with dementia/CIND, and 34.0% of those without, with an overall classification 
success rate of 37.0%. 
To further examine the predictive utility of MDD and PTSD, another model was built 
adjusting for CurrentAge. This model was statistically significant, χ2(3, N = 4800) = 79.40, p < 
.000. When age and PTSD were both held constant, a history of MDD almost doubled the risk of 
dementia/CIND, OR = 1.82, 95% CI [1.36, 2.44], and showed a moderate association with the 
outcome. In contrast, when MDD and age were controlled for, the predictive utility of PTSD 
slightly decreased, yet remained statistically significant with a moderate association with 
dementia/CIND, OR = 1.63, 95% CI [1.22, 2.18]. 
To demonstrate the impact of MDD and PTSD with and without adjustment for 
CurrentAge, a line graph was created to represent the mean predicted probabilities by Veterans’ 
current age, including both adjusted and unadjusted models of MDD and PTSD (see Figure 3). In 
the unadjusted model, the risk of dementia/CIND based on MDD history generally declined as 
subjects’ age increased. The PTSD line was indicative of a higher risk as age increases, and then 
89 
 
a significant drop in risk the closer Veterans were to 70 year of age. This potentially suggested 
that MDD was a significant risk for dementia/CIND despite a Veteran’s age, whereas PTSD 
(when controlling for age) increased the risk of dementia/CIND as Veterans become older. PTSD 
appeared to be the greatest risk factor in the unadjusted model, whereas MDD was the greatest 
risk factor in the adjusted model.  
Model 1: MDD, PTSD, sex, and race. A hierarchical logistic regression analysis was 
conducted to examine the predictive utility of MDD, PTSD, and demographic variables as risk 
factors of dementia/CIND, adjusting for subjects’ current age (Model 1a). CurrentAge, PTSD, 
sex, and race were entered into this model based on their significance in prior bivariate analyses. 
MDD was also included based on the literature in which several researchers have determined it 
to be a significant risk factor of dementia/CIND (Barnes et al., 2012; Byers & Yaffe, 2011; Chen 
et al., 2009; Kaup et al., 2016).  
CurrentAge was entered into block 1, MDD and PTSD into block 2, and race and sex into 
block 3. Block 2 (MDD and PTSD) significantly contributed to the model, with a change in χ2 
value of 18.55, p < .000. Adding race and sex to the model resulted in a smaller, yet significant 
change in χ2 value of 7.42, p = .024, with an overall statistically significant model, χ2 (5, N = 
4800) = 86.83, p < .000). However, the Nagelkerke R2 of .05 indicated a weak relationship 
between prediction and grouping. The Hosmer-Lemeshow test was not significant χ2(8, N = 
4800) = 6.53, p = .589, thus supporting the assumption that the model adequately fit the data. 
With a classification cutoff of .07, the model was able to correctly classify 59.8% of subjects 
with dementia/CIND and 61.3% of subjects without dementia/CIND, for an overall success rate 
of 61.2%.  
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When a .05 criterion of statistical significance was employed, three of the four variables, 
MDD (p < .000), PTSD (p = .001), and sex (p = .022), were statistically significant when all 
other variables in the model were held constant (as shown in Table 7). A history of MDD was 
moderately associated with dementia/CIND, and Veterans with a history of MDD had almost 
twice the risk, OR = 1.80, 95% CI [1.34, 2.42]. Subjects with a history of PTSD (OR = 1.62, 
95% CI [1.21, 2.16]) had over one and a half times the odds of getting dementia/CIND (b = .48, 
Wald χ2(1) = 10.63, p = .001) when compared to those without a history. While statistically 
significant (p = .022), the odds for male Veterans were only slightly greater than the odds for 
female Veterans, OR = .76, 95% CI [.60, .96].  
In the next step, Model 1b, interactions between sex (female = “1” and male = “0”) and 
MDD, and sex and PTSD were added. Interactions between race and MDD, and race and PTSD 
were also included. CurrentAge was entered into the first block, MDD, PTSD, and the 
demographic variables into the second block, and the new interaction variables into the third 
block. Although the model as a whole was statistically significant, χ2(9, N = 4,800) = 91.81, p < 
.000, the interactions did not significantly improve the model’s prediction validity, χ2(4, N = 
4,800) = 4.98, p = .289. When examining the effect of each variable when all others were held 
constant, only CurrentAge was statistically significant (p < .000). Model 1b was able to correctly 
classify 60.1% of dementia/CIND incidents and 60.2% of non-dementia/CIND incidents, for an 
overall classification success rate of 60.2%. 
To discover optimal grouping and achieve parsimony, all predictors from Model 1b were 
entered into one block using a backward LR method for Model 1c. This method yielded the 
following predictors: CurrentAge, MDD, PTSD, sex, race, and Race*MDD (see Model 1c in 
Table 7). The model was statistically significant, χ2(6, N = 4,800) = 91.50, p < .000, however, the 
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overall models with this particular set of variables had similar predictive utility as Models 1a and 
1b.  
When examining individual variables’ predictive utility, five out of six variables were 
statistically significant (p < .05), with MDD (p = .058) being the only variable not significantly 
contributing to the model. Model 1c was able to correctly classify 58.6% of dementia/CIND 
cases and 60.9% of non-dementia/CIND cases, for an overall success rate of 60.8% (see Table 10 
for observed and predicted frequencies). Similar to Model 1a, a history of PTSD was associated 
with a 1.62, 95% CI [1.21, 2.16], greater likelihood of developing dementia/CIND (b = .48, 
Wald χ2(1) = 10.69, p = .001) in Model 1c. Men were .76, 95% CI [.60, .96], times more at risk 
of dementia/CIND compared to women. Interestingly, the strongest significant predictor of 
dementia/CIND in Model 1c was Race*MDD, b = .52, Wald χ2(1) = 4.66, p = .031, which 
showed that when compared to their White counterparts, Black Veterans had almost twice the 
risk of getting dementia/CIND when a history of MDD was also present, OR = 1.67, 95% CI 
[1.05, 2.67].  
Model 2: Sex, MDD, PTSD, MDDduration, and PTSDduration. With the aim of 
specifying risk factors based on demographic characteristics, Model 2 was built using sex, MDD, 
PTSD, and interactions between the predictors (sex*MDD and sex*PTSD), continuing to adjust 
for CurrentAge (see Table 8). In Model 2a, a hierarchical logistic regression analysis was used in 
which CurrentAge was entered into the first block, MDD and PTSD into the second, and sex into 
the third. Adding sex to the model significantly improved the model, based on the increase in the 
chi-square value, χ2(1, N = 4800) = 5.16, p = .023.  
Model 2a, overall, was also statistically significant, χ2(4, N = 4800) = 84.56, p < .000, 
with a Nagelkerke R2 of .044. When examining individual variables’ impact on the model, all 
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three variables were statistically significant (p < .05), with similar effects of MDD, OR = 1.81, 
95% CI [1.35, 2.43], and PTSD, OR = 1.61, 95% CI [1.21, 2.15], as those found in Model 1a. 
However, sex was found to have a weak association with dementia/CIND, OR = 0.76, 95% CI 
[0.60, 0.97]. Model 2a was able to correctly classify 60.7% of dementia/CIND incidents and 
61.2% of non-dementia/CIND incidents, for an overall classification success rate of 61.1% (see 
Table 10). 
Model 2b consisted of the examination of the two interaction variables between sex and 
MDD/PTSD. CurrentAge was entered into block 1, MDD, PTSD, and sex into block 2, and 
sex*MDD, and sex*PTSD into block 3. Although the overall model, when compared to a 
constant only model, was statistically significant, χ2(6, N = 4800) = 85.77, p < .000), adding the 
interactions did not result in a significant improvement in the predictive validity of the model 
χ2(2, N = 4800) = 0.22, p = .898. Model 2b also yielded the same classification success rates as 
Model 2a. In the third step, a backward LR method was used to enter all the predictors from 
Model 2b. However, this method yielded a model identical to Model 2a, hence it was it not 
included in Table 8.  
Similar procedures were employed to analyze sex and MDDduration and PTSDduration. 
The steps taken in Model 2duration yielded comparable outcomes to steps taken in Model 2, but 
with smaller associations between predictor and outcome variables. The final step of Model 
2duration is also included in Table 8. Overall, Models 2 and 2duration suggested that when the effects 
of MDD and PTSD were held constant, male Veterans had a slightly greater risk for 
dementia/CIND compared to their female counterparts.  
Model 3: Race, MDD, PTSD, MDDduration, and PTSDduration. As demonstrated in 
Table 9, Model 3 consisted of similar procedures as those in Model 2, but with race as the 
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demographic variable under investigation. Model 3a, which was adjusted for age and included 
race, MDD, and PTSD, was statistically significant when compared to a constant only model, 
χ2(4, N = 4800) = 81.52, p < .000, with a Nagelkerke R2 of 0.04. However, adding race to the 
model did not significantly improve its prediction utility, χ2(1, N = 4800) = 2.11, p = .146, nor 
was it statistically significant when holding all other predictors constant, p = .147. MDD, OR = 
1.81, 95% CI [1.35, 2.42], and PTSD, OR = 1.64, 95% CI [1.23, 2.18], however, were 
significant and had moderate associations with dementia/CIND, with OR values comparable to 
those found in Models 1a and 2a. Model 3a was able to correctly classify 65.2% of 
dementia/CIND incidents and 58.7% of non-dementia/CIND incidents, for an overall 
classification success rate of 59.1%. 
Race*MDD and Race*PTSD were included in Model 3b, using the same block entry 
procedures as in Model 2b, which resulted in a statistically significant model, χ2(6, N = 4800) = 
86.28, p < .000, with a Nagelkerke R2 value of .05. However, adding the interactions to the 
model did not significantly improve its predictive utility, χ2(2, N = 4800) = 4.76, p = .092. 
Further, although neither interaction variable was statistically significant, the p value for 
Race*MDD was .058, which was slightly greater than the criterion for statistical significance.  
In Model 3c, all the variables from 3b were entered using backward LR method, which 
yielded CurrentAge, MDD, PTSD, race, and Race*MDD in the last step. These variables 
resulted in a statistically significant model, χ2(5, N = 4800) = 86.18, p < .000, yet the models 
predictive utility decreased from that of Model 3a. Nonetheless, this model revealed a statistically 
significant moderate association between race and history of MDD, OR = 1.67, 95% CI [1.05, 
2.67]. A history of PTSD was also associated with similar risks of developing dementia/CIND, 
OR = 1.64, 95% CI [1.23, 2.19]. Hence, although race was not found to be statistically 
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significant in previous models (e.g., Models 1a and 3a), its interaction with MDD (Race*MDD) 
was associated with a 1.67, 95% CI [1.05, 2.67], increase in risk among Black Veterans for 
dementia/CIND.  
The significant moderate association of Race*MDD with dementia/CIND was also found 
in Model 1c where sex was also included in the model (Table 7). In Model 3duration, the same 
methods from Model 3 were employed and Race*MDDduration was also the only interaction 
variable yielded in the backward LR analysis. The findings for the steps in Model 3duration were 
also similar to those of Model 3, yet with smaller associations among predictor and outcome 
variables. Model 3c correctly classified 62.2% of dementia/CIND incidents and 61.6% of non-
dementia/CIND incidents, for an overall classification success rate of 61.7% (see Table 10). 
To further demonstrate the predictive validity of the logistic regression models with sex 
(Model 22) and race (Model 3c), line graphs with mean predicted probabilities for 
dementia/CIND were created (see Figure 4). The line graph for Model 2a shows the higher risk 
for male Veterans compared to female Veterans, despite differences in psychiatric history. The 
line graph for Model 3c displays the increased risk for Black Veterans when a history of MDD 
was present. Consistent in both line graphs, Veterans who were male, and White, had the highest 
risk if a history of PTSD was present.   
Model Validity and Discrimination Power 
The overall logistic regression models of this study were statistically significant in 
predicting dementia/CIND. The study hypothesis—Veterans with a history of MDD or PTSD 
(first diagnosed before age 55) would have a greater likelihood of dementia/CIND—was 
supported by the findings. However, Veterans’ current age had an important influence on the 
amount of risk associated with each disorder. When controlling for the other, MDD and PTSD 
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increased the risk of dementia/CIND 1.5 to 2.0 times compared those without a history of the 
diagnoses. When age was adjusted for, the predictive ability of MDD increased, whereas the risk 
of PTSD decreased slightly. When demographic variables were examined for predictive ability, 
Black Veterans were 1.67 more likely to develop dementia/CIND if a history of MDD was 
present. The interaction between race and history of PTSD however, was not significant in this 
study. Further, male Veterans had a slightly greater risk than female Veterans.  
To assess the overall effectiveness of the final models, receiver operating characteristic 
(ROC) curve analyses were conducted to obtain a visual of the proportion of true positives 
plotted against the proportion of false positives. The area under the ROC (AUROC) curve values 
for Model 1c (AUC = .654, 95% CI [.626, .683]), Model 2a (AUC = .648, 95% CI [.619, .677]), 
and Model 3c (AUC = .651, 95% CI [.623, .680]) are shown in Figure 5. An AUC of 0.5 suggests 
a 50-50 chance of accurate discrimination among diagnosis (Kumar & Indrayan, 2011). The 
closer the AUC is to 1.00, the better the diagnostic accuracy of the model or measure. AUC 
values from .70 to .80 have been considered fair/good in the existing literature (Maroco et al., 
2011). 
Researchers have identified an AUROC median value of 0.72 as “acceptable” in research 
studies focusing on risk factors of dementia and related conditions (Maroco et al., 2011). In this 
study, all three models had similar AUROC values ranging from .648 to .654, which fall below 
the “good” range of .70 to .80 (Hanley & McNeil, 1982). However, all three models showed 
statistically significant predictive power (p < .000), and the AUROC values fell slightly below 
the discrimination ability considered suitable within the context of this study. Further, based on 
the classification cutoff of .07 that was determined from disease rate, sensitivity values of 58%, 
61%, and 62%, and specificity values of 62%, 61%, and 62% were determined for Models 1c, 2a, 
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and 3c, respectively. Predictive accuracy of the models did not differ based on history of MDD or 
PTSD, duration of MDD or PTSD, sex, and race, although the variables included in each model 
varied.  
Discussion 
Researchers have made great strides in the inclusion of minority groups in recent studies 
involving the general population (Akincigil et al., 2012; Alegria et al., 2008; Mezuk et al., 2010; 
Yaffe et al., 2013). The current knowledgebase on risks of dementia/CIND, especially for 
different groups, has also proliferated (Barnes et al., 2012; Mielke et al., 2014; Plassman et al., 
2007). For example, it has been established that a substantial risk factor of dementia and other 
forms of cognitive impairment is hypertension, which disproportionately impacts Black 
individuals (Manly & Echemendia, 2007). With the recent efforts of the VA to include women 
and racial minorities in research has also lead to an increase in studies including minority 
Veteran groups (Long et al., 2006). However, there continues to be a need for further rigorous 
testing of risk factors of dementia and related conditions for the Veteran population, especially 
among racial minority groups (Long et al., 2006; Saha et al., 2008). 
The current study is one of the few examining dementia/CIND risk factors for the 
Veteran population aged ≥ 60 and including equal numbers of persons from various demographic 
groups, such as Black, White, female, or male. The findings of this study further confirmed the 
significant risk that depression, specifically MDD (Byers et al., 2012), and PTSD (Yaffe et al., 
2010) pose for this particular population, and also contributed to the larger efforts for VA studies 
to include minority groups (Long et al., 2006) in studies related to dementia and other forms of 
cognitive impairment.  
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The hypothesis (Veterans with a history of MDD or PTSD would be at greater risk of 
dementia/CIND) was confirmed by the findings. Specifically, when controlling for the other, 
MDD and PTSD increased Veterans’ risk of developing dementia/CIND almost twofold. 
Regarding the predictive utility of race and sex, Black Veterans had almost double the risk of 
developing dementia/CIND compared to their White counterparts, if a history of MDD was 
indicated. Sex was a significant risk, which indicated that male Veterans had a greater risk 
compared to female Veterans; yet, the effects for sex were very small. Further, having a history 
of MDD or PTSD did not affect risk for dementia/CIND based on Veterans’ sex (e.g., 
interactions between sex and the psychiatric conditions were not significant).    
It is worthwhile to note that the interaction between race and PTSD was not statistically 
significant, and this finding was contrary to recent studies that show PTSD rates are significantly 
higher in Black Veterans than their White counterparts (Dursa et al., 2014). For example, 
research on racial differences in PTSD rates among Veterans from OEF/OIF conflicts shows 
significantly higher PTSD rates among Black Veterans (Dursa et al., 2014). Further, when 
Dohrenwend et al. (2008) studied PTSD prevalence rates of Vietnam Veterans utilizing record-
based exposure measures and clinical diagnoses of sub-samples, they also found greater rates of 
PTSD among Black (and Hispanic) Veterans for this age group. The researchers emphasized that 
previous research on racial differences in PTSD rates relied on retrospective self-reports and also 
focused on the presence of the disorder at the time the study was conducted, which frequently 
was several years after the Vietnam War.   
Importantly, David, Kutcher, and Mellman (1999) assessed comorbidities found among 
male Veterans, 91% of whom were from the Vietnam era, reporting psychotic symptoms of 
PTSD. They found psychotic symptoms were associated with MDD and that this comorbidity 
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was more common among Black and Hispanic Veterans compared to White Veterans. Such 
findings are noteworthy in the context of this study due to the age group (60 years or older) of 
the Veteran participants [in this study], as well as the war era in which they served. To attribute 
for the discrepancies between the current study and other recent research on racial differences in 
PTSD rates, consideration of David and colleagues’ (1999) findings is important. For instance, it 
is possible that Black Veterans in this age group were more likely to be diagnosed with MDD 
associated with psychotic features, whereas PTSD may have been a diagnosis that was more 
commonly found among White Veterans. However, additional studies addressing the limitations 
of inconsistent findings regarding PTSD rates are needed to fully understand the risk for different 
groups of Veterans. 
Prevalence Rates 
The rates of dementia/CIND diagnosis in this Veteran population were similar to that of 
the general population, which is consistent with most of the existing literature (Veitch et al., 
2013; World Health Organization, 2015). Although the numbers are slightly varied, researchers 
have also recently found similar prevalence rates of dementia in the Veteran population (Sibener 
et al., 2014; Yaffe et al., 2010). However, findings comparing prevalence rates of 
dementia/CIND in the general population versus the Veteran population is somewhat 
inconsistent and robust findings have yet to be reported (Veitch et al., 2013). Prince and 
colleagues (2013) reported that the worldwide prevalence rate of dementias range from 5 to 7 
percent in the general population. It is probable there are 7 percent [the high end of the rates for 
the general population] of positive cases in the current study due to the inclusion of CINDs, as 




Although slightly varied, the current prevalence rate of dementia of Veterans is expected 
to be similar to that of the general population; nonetheless, researchers are in agreement 
concerning the increased risk that U.S. Veterans are at of developing cognitive impairment and 
dementia (Veitch et al., 2013). This is particularly so considering the “baby boomer” generation 
that makes up a large portion of the Veteran population and the increased risks they encounter 
(Sibener et al., 2014; Veitch et al., 2013). Of the U.S. population 60 years of age and older, 22 
percent are Veterans. More specifically, almost half of the men aged 60 or older are Veterans 
(Veitch et al., 2013), part of the “baby boomer” generation (Hebert et al., 2013).  
The “baby boomer” generation has been identified as anyone born between 1946 and 
1964 (U.S. Census Bureau, 2008). Researchers have already documented the steady rise in 
prevalence rates of dementia; for example, from about 4.5 million individuals in 2000 (Hebert, 
Scherr, Bienias, Bennett, & Evans, 2003) to 4.7 million in 2010, and estimated to be 13.8 million 
by 2050 (Hebert et al., 2013). This number is expected to continually rise as “baby boomers” 
approach age 70 and older (Hebert et al., 2013). All subjects in this study are considered to be 
part of the “baby boomer” population given the U.S. Census Bureau’s (2008) definition of the 
term.  
The findings of this study demonstrated that individuals diagnosed with dementia/CIND 
are older than those without, which is also consistent with the literature. However, important to 
highlight is that the first set of analyses conducted with Veterans diagnosed with dementia/CIND 
at age ≥ 60 (n = 210) were largely insignificant. Yet, analyses of Veterans with dementia/CIND 
diagnosed at age ≥ 56 (n = 336) resulted in generally significant findings and a much higher rate 
of dementia/CIND. The age subjects were diagnosed with dementia ranged from 60 to 70 (M = 
63.13, SD = 2.52) in the first set of analyses, and 56 to 70 (M = 60.83, SD = 3.18) in the second 
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set. Hence, across a span of four years (when subjects were diagnosed with dementia/CIND 
between ages 56 to 59), 126 additional Veterans were diagnosed. This potentially indicates that 
Veterans begin experiencing cognitive impairments earlier (at age 56) than the general 
population (at age 60; Prince et al., 2013), which is not surprising given the increased risk this 
population has for diseases found among older adults.  
MDD and PTSD 
In general, PTSD and MDD were both significant risk factors of dementia/CIND for 
Veterans, increasing their odds anywhere from about 1.5 to 2.0 times. Importantly, there were 
other factors, such as current age, that moderated these risk levels. MDD as a risk factor, when 
other variables were not considered, did not pose a significant threat. However, when the age of 
subjects was controlled for, MDD was associated with almost a twofold risk of dementia/CIND. 
Conversely, a history of PTSD, when other variables were not considered, was a strong risk 
factor. Yet, when controlling for Veterans’ age, PTSD was not a statistically significant risk. 
This potentially indicated that PTSD as a significant risk varied based on a Veterans’ age. A 
history of MDD alone [prior to age 55] acted as a significant risk for dementia and related 
conditions, whereas a history of PTSD acted as a strong risk factor especially later in life.  
When each disorder (MDD and PTSD) was examined while holding the other constant, 
they were both significant risk factors and had a moderate association with dementia and related 
conditions. Notably, when current age, and either PTSD or MDD, were also controlled for, MDD 
became an even greater risk, whereas the risk that PTSD posed decreased slightly. Specifically, 
when controlling for PTSD and age, MDD almost doubled the risk of dementia/CIND, whereas 
PTSD increased the risk over one and a half times. Comparable, yet smaller, associations were 
found for MDD and PTSD chronicity. 
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Sex and Race 
A history of MDD or PTSD independently posed a greater risk for dementia/CIND 
compared to Veterans’ demographic characteristics. Nevertheless, sex and race still were 
significant risk factors in different ways. Male Veterans were at a slightly higher risk of 
developing cognitive difficulties compared to female Veterans.  Independently (when holding all 
other variables in the model constant), sex acted as a significant risk whereas race did not. Black 
Veterans’ risk of dementia/CIND almost doubled when they had a history of MDD. This is an 
important finding, because researchers have found that Black individuals are less likely to have a 
depression diagnosis, and receive treatment for depression, compared to their White counterparts 
(Akincigil et al., 2012). It is possible this phenomenon also occurs in the Veteran population, and 
that is why a combination of Black racial identification and a history of MDD resulted in a 
significantly greater risk. The relationship between sex and MDD, and sex and PTSD were not 
significant.  
Without adjusting for other variables, men were at slightly greater risk compared to 
women. As age increased though, women’s risk became greater, particularly at age 70 or older. 
White Veterans had generally higher rates of dementia/CIND than Black Veterans when a 
history of PTSD was present, whereas Black Veterans had greater risks if a history of MDD was 
present. Both female and male Black Veterans’ risk increased almost twofold if a history of 
MDD was present. 
Findings Unique to Veterans of Age ≥ 60 Years 
It is important to note particular findings that were unique to the Veteran population aged 
60 or older, when compared to the general U.S. population. When studying the number of 
dementia/CIND cases in this study, White male Veterans with a history of PTSD had the higher 
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number of diagnoses, with Black male Veterans with a history of MDD following. Women 
consistently had lower rates of dementia/CIND diagnosis, and the rates were similar for most of 
the Black female and White female Veteran groups.   
In the general population, Black persons have a greater risk compared to their White 
counterparts for dementia and related conditions (Plassman et al., 2007; Yaffe et al., 2013). Race 
alone did not significantly affect risk for dementia/CIND in this study. However, Black Veterans 
had much greater odds of developing cognitive problems when a history of MDD was present. In 
a setting (VA medical centers) where barriers to health care costs are minimized and the 
population (Veterans) is unique in that it is exposed to greater amounts of adverse circumstances, 
Black Veterans nonetheless continue to be at a greater risk provided they have a history of MDD.  
Further, male Veterans continually had greater risks for dementia/CIND compared to 
their female counterparts, which is understandable considering the different roles male and 
female Veterans (current age of ≥ 60) had when serving in the military (Vogt et al., 2011). In the 
past, women’s role in the military have been characterized as primarily clerical or nursing staff, 
whereas their roles in current conflicts in Afghanistan and Iraq entail much higher levels of 
combat exposure (Street, Vogt, & Dutra, 2009; Vogt et al., 2011). Nevertheless, this is a unique 
finding provided that most of the research on dementia prevalence rates identifies women as 
having significantly greater probabilities. There are some researchers, however, who have 
reported the higher rates could be due to women’s longer longevity compared to that of men’s, 
and others who indicate many other factors also influence women’s higher levels of risk (Viña & 






 Despite the significant impact that dementia and related conditions have on affected 
persons and their loved ones, it is a condition that is seen in older individuals and is rare among 
the general population. The World Health Organization (2015) reported the prevalence rate of 
dementia for those aged 60 and older to be approximately 5 to 8 percent. Although this rate is 
expected to increase, particularly within the Veteran population (Veitch et al., 2013), the current 
prevalence rate makes dementia and related conditions difficult to investigate and determine 
concrete findings. Thus, this study is not without its limitations.  
 Dementia and cognitive impairment not demented (CIND) were grouped together in this 
study, hence, it is possible potential differences or patterns among those diagnosed with 
dementia versus CINDs may have existed. This will be an important objective in future 
research—to examine how subtypes of dementia and related conditions differ with respect to risk 
factors. Although all specifiers were considered for major depressive disorder (duration, severity, 
presence of psychotic behavior, and remission status) and posttraumatic stress disorder (cute, 
brief, and chronic), these were two exclusive psychiatric conditions examined in this study. 
These disorders are known to impact Veterans at a greater rate, intensity, and duration (Veitch et 
al., 2013), nonetheless, researchers should investigate other related psychiatric conditions as 
risks of dementia/CIND. Further, examination of the comorbidity of these conditions across 
diverse Veteran groups is also needed, especially due to the similarity in symptoms and high 
rates of comorbidity (Angelakis & Nixon, 2015).  
Likewise, other factors with strong predictive utility of dementia and related conditions 
identified in the literature, such as hypertension for Black individuals (Yaffe et al., 2013), 
traumatic brain injury (TBI) for Veterans (Veitch et al., 2013), and genetic risks of dementia 
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(Chen et al., 2009), were not examined in this study. It would be advantageous for researchers to 
study the influence of these variables on Veterans of various demographic backgrounds. Scholars 
have found that treatment of mental health conditions, such as MDD, can improve cognitive 
functioning in some persons (Herrera-Guzmán et al., 2010), thus, researchers should also 
examine the potential impact that obtaining treatment for depression and PTSD might have on 
the outcome of risk of dementia/CIND. Moreover, the diagnosis of MDD and PTSD made by 
licensed independent providers were examined in this study, yet actual depressive or PTSD 
symptoms were not assessed. Thus, readers must remember that the findings are solely based on 
diagnoses that were made rather than the observation of actual symptoms via mood 
questionnaires (e.g., Geriatric Depression Scale), clinical interviews, etc.   
In order to obtain adequate statistical power, this study included only Veterans who self-
identified as Black or White, thus, omitting other racial groups such as Veterans who identified 
as having more than one race (e.g., “mixed” or both Black and White). It should also be noted 
that the final sample in each of the 12 groups were randomly selected from the larger Cohort 
tables, which consisted of fewer records for women, particularly those who self-identified as 
Black, compared to the medical data available for men. As the Veteran population continues to 
diversify and data for other racial groups becomes available, it will be imperative for researchers 
to include data of these Veterans in future studies to provide findings applicable to more Veteran 
subpopulations.  
 Although statistically significant, the logistic regression models had small pseudo R2 
values (e.g., Nagelkerke R2) ranging from .04 to .05. Further, the ROC curve analysis showed the 
discrimination ability of the models were slightly less than what is considered “acceptable” in the 
context of this study. To increase the chances of detecting prediction validity of study variables 
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based on a low disease rate of 7%, a larger sample than what was indicated by the a priori 
statistical power analysis was included in this study. This resulted in having statistical tests that 
were “overpowered,” and smaller values or effects may have been determined to be statistically 
significant by inflated p values.  
Taking this into consideration, the study findings were also largely interpreted using 
effect size as measured by the odds ratio values (Chen et al., 2010; Cohen, 1992), which were 
found to be in the weak to moderate range. This way, the amount of association that existed 
among variables were examined rather than basing the findings solely on p values. Furthermore, 
when statistical tests are potentially “overpowered,” the clinical significance of the statistically 
significant results are called into question. Thus, both the statistical and clinical significance of 
the study findings will be considered when discussing implications.   
Implications 
The findings of the current study have important implications for both clinicians and 
researchers. Notably, Veterans in this study were at an accelerated risk of cognitive difficulties—
they were more likely to experience cognitive impairment earlier than persons in the general 
population. Sperling and others (2011) identified a “preclinical stage” that can be a major target 
for preventative treatment approaches of dementia/CIND, as changes in the brain are suspected 
to begin several years prior to the actual onset of symptoms related to cognitive impairment. 
Clinicians must take this, as well as the accelerated risk of Veterans, into consideration. 
Preventative efforts in this regard would be very advantageous, particularly for younger 
Veterans. For researchers, it is important to include Veterans from younger age groups to further 
examine the typical onset of cognitive difficulties for this special population. Researchers have 
determined younger Veterans are at a greater risk for PTSD, hence, these findings overall have 
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significant implications particularly for those Veterans involved in recent OEF/OIF conflicts 
(Qureshi et al., 2010; Seal et al., 2009).  
Based on the significance of both MDD and PTSD as risk factors for Veterans aged ≥ 60 
years, greater attention to the assessment and treatment of depression and PTSD is warranted. 
MDD was a risk factor despite Veterans’ current age, whereas PTSD generally appeared to be a 
significant risk factor as Veterans increased in age. Despite the examination of these conditions 
separately in this study, MDD and PTSD nonetheless have comparable symptoms (Asnaani et 
al., 2010; Spinhoven et al., 2014). Taking into consideration the significant effects of both 
conditions, it would be advisable for clinicians to conduct brief depression/PTSD screens 
especially for older Veterans (Byers et al., 2012; Casey, 2012; Djernes, 2006); that way, if 
further assessment or treatment is warranted, there are increased chances it will be detected.   
Important to note about MDD and PTSD symptoms is the difference in emotion and 
symptom expression among men and women, particularly for older adults and Veterans (Djernes, 
2006). Bouchard and Shih (2013) emphasized how men are less likely to express depressive 
symptoms compared to women, potentially due to societal gender stereotypes (Essau et al., 
2010). Women are more interpersonally oriented and have greater chances of experiencing 
interpersonal stress compared to their male counterparts, which researchers have attributed as 
one of the significant causes of such disparities in rates of depression (Bouchard & Shih, 2013). 
For that reason, psychoeducation related to psychiatric symptoms and the differences in 
symptom expression among demographic groups is important to include in patient/Veteran 
treatment care. This is not to suggest that all male Veterans may attempt to conceal their 
psychiatric symptoms, but rather that due to socialization and gender stereotypes, men and 
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women express these symptoms quite differently and it may be difficult to recognize symptoms 
in one versus the other (Essau et al., 2010).   
Time and time again, scholars have provided evidence of persons’ racial background 
playing a significant role in their health outcomes (Alegria et al., 2008; Oh, Galanter, Thakur, 
Pino-Yanes, White, et al., 2015), and this proves to be no different for the Veteran population 
(Saha et al., 2008). Specifically, Black Veterans with a history of MDD should be given 
additional consideration with respect to health care due to their increased risk of cognitive 
impairment. In this study, the interaction variable between history of MDD and race 
(Race*MDD) was statistically significant and almost doubled the odds of a Black Veteran 
developing dementia or a related condition. This is particularly critical considering the racial 
disparities in diagnosis that disproportionately impact Black individuals (Eack et al., 2012). 
Further, researchers must also consider the relationship between MDD and race in future studies, 
especially when studying the Veteran population. 
Although the potentially “overpowered” statistical analyses of this study may have 
produced inflated p values resulting in statistical significance of smaller differences, it is 
important to inspect such results for their clinical significance. For example, the difference in 
mean PTSD duration among Veterans with dementia/CIND (M = 14.28 years, SD = 2.26) 
compared to those without (M = 13.54 years, SD = 2.47) was statistically significant, yet the 
absolute difference between the two age means, in years, is less than one year. This may cause 
readers to question the clinical significance of such a finding, however, it is important to 
consider the difference within the context of the study. Specifically, experiencing PTSD 
symptoms for an additional six months for a Veteran may be quite devastating and potentially 
result in a significantly lower quality of life, which could lead to higher risks for various medical 
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conditions. The findings for MDD duration were similar. Thus, when working with Veterans 
experiencing mental health conditions, clinicians must be cautious not to minimize the toll that 
an additional six months of adverse mental symptoms can take. Likewise, researchers should 
also further inspect findings typically considered to be “small” based on the context of their 
study.   
Conclusion 
 As one of the few studies including various demographic groups of the Veteran 
population, the findings related to risk factors of dementia and related conditions can hopefully 
lay the groundwork for future researchers to investigate how risk factors of cognitive difficulties 
in the Veteran population differ from those found in the general population. MDD and PTSD 
were both identified as significant risk factors, particularly when the other was controlled for. 
Male Veterans had a slightly greater risk of developing cognitive difficulties compared to female 
Veterans of this study. Black Veterans had almost double the risk of developing dementia or 
related conditions when a history of MDD was indicated. The findings also indicated that the 
Veteran population may be more likely to experience an earlier onset of cognitive difficulties 
compared to the general population.  
Continual brief assessment and treatment of symptoms [if warranted] related to 
depression, especially MDD, and PTSD will be an important initiative for providers working 
with Veterans (Casey, 2012; Fanning & Pietrzak, 2013; Kaup et al., 2016). Practices such as 
these can potentially act as one of the greatest preventative treatment approaches for dementia 
and related conditions. As the aging Veteran population also diversifies based on sex and race 
(U.S. Census Bureau, 2012), an essential task for researchers and clinicians is to consider such 
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demographic variables in their work to provide care employing best practices and better serve 
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Groups of Veterans by Sex, Race, and History of Psychiatric Disorder (N = 4,800) 
Race/Sex 
Cohort 1  Cohort 2  Cohort 3  
(MDD) (PTSD) (No MH history) 
Black/Female C1G1 C2G4 C3G9 
White/Female C1G2 C2G5 C3G10 
Black/Male C1G3 C2G6 C3G11 
White/Male C1G4 C2G7 C3G12 
Note. C# = cohort number. G# = group number. Cohorts were based on psychiatric history 
diagnosed at age < 55. Cohort 1 = major depressive disorder (MDD) was the only psychiatric 
diagnosis. Cohort 2 = posttraumatic stress disorder (PTSD) was the only psychiatric diagnosis. 
Cohort 3 = no psychiatric history. Individuals with a history of both MDD and PTSD were 
excluded from the study. Individuals who identified as having more than one sex and/or race 




Characteristics of Veterans with and without Dementia/CIND (N = 4,800) 
Veteran  
Characteristic n (% of N) 
DEM/CIND Status With DEM/CIND 
Yes 
(n = 336) 
No 





aCurrent age** — 65.64 (2.50) 64.49 (2.57) — — 
aDEM/CIND dx age — 60.83 (3.18) — — — 
      
MDD (Cohort 1) 1,600 (33.3%) 124 (7.8%) 1,476 (92.3%) 36.9% 2.6% 
aMDD dx age — 51.26 (2.30) 50.76 (2.48) — — 
aMDD duration* — 13.76 (2.24) 13.21 (2.40) — — 
aDEM/CIND-MDD dx — 8.95 (3.40) — — — 
      
PTSD (Cohort 2)* 1,600 (33.3%) 131 (8.2%) 1,469 (91.8%) 39.0% 2.7% 
aPTSD dx age — 51.70 (1.89) 51.31 (2.32) — — 
aPTSD duration** — 14.28 (2.26) 13.54 (2.47) — — 
aDEM/CIND-PTSD dx — 9.52 (3.29) — — — 
      
Sex**      
Female 2,400 (50.0%) 131 (5.5%) 2,269 (94.5%) 39.0% 2.7% 
Male 2,400 (50.0%) 205 (8.5%) 2,195 (91.5%) 61.0% 4.3% 
      
Race*      
Black 2,400 (50.0%) 148 (6.2%) 2,252 (93.8%) 44.0% 3.1% 
White 2,400 (50.0%) 188 (7.8%) 2,212 (92.2%) 56.0% 3.9% 
      
Marital Status      
Single/Unmarried 693 (14.6%) 58 (8.4%) 635 (91.6%) 17.3% 1.2% 
Married 1,853 (39.0%) 117 (6.3%) 1,736 (93.7%) 34.8% 2.5% 
Divorced/Separated 1,896 (39.9%) 136 (7.2%) 1,760 (92.8%) 40.5% 2.9% 
Widowed 306 (6.4%) 25 (8.2%) 281 (91.8%) 7.4% 0.5% 
TOTAL 4,800 (100%) 336 (7.0%) 4,464 (93.0%) — — 
Note. DEM/CIND dx age = first dementia/CIND diagnosis at age > 55. MDD/PTSD dx age = 
first MDD/PTSD diagnosis at age < 55. MDDduration and PTSDduration = # of years since first 
MDD or PTSD diagnosis, respectively. DEM/CIND-MDD/PTSD dx = number of years between 
the first DEM/CIND and the first MDD/PTSD diagnosis. Individuals with a history of both 
MDD and PTSD were excluded from the study. Subjects who identified as having more than one 
sex and/or race were also excluded. 
aContinuous variables expressed as mean (with standard deviation). All other variables were 
categorical and expressed as frequency (percentage). 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































(n = 336) 
Without DEM/CIND 
(n = 4,464) χ2(1) value p 
MDD 124 (7.8%) 1,476 (92.3%)     2.07 .150 
PTSD 131 (8.2%) 1,469 (91.8%)     5.20* .023 
Sex   
  17.52** .000 Malea 205 (8.5%) 2,195 (91.5%) 
Female 131 (5.5%) 2,269 (94.5%) 
Race   
    5.12* .024 Whitea 188 (7.8%) 2,212 (92.2%) 






DEM/CIND t value p 
CurrentAge (n = 336) 
65.54 (2.50) 






MDDduration (n = 124) 
13.76 (2.24) 






PTSDduration (n = 131) 14.28 (2.26) 






Note. DEM/CIND = first dementia/CIND diagnosis at age > 55. MDD and PTSD coded as “0” 
(no history of MDD/PTSD at age < 55) or “1” (with a history of MDD/PTSD at age < 55). 
Reference group for MDD and PTSD was Cohort 3 (no psychiatric history at age < 55). Sex 
included Female (coded as “1”) and Male (coded as “0”). Race included Black (coded as “1”) 
and White (coded as “0”). MDDduration and PTSDduration = # of years since first MDD/PTSD 
diagnosis, respectively. Categorical predictor variables are reported as frequency (with 
percentage) and continuous predictor variables are reported as mean (with standard deviation). 
aReference group for the categorical predictor variables of sex and race. 
bLevene’s test indicated unequal variances (F = 6.76, p = .009). Degrees of freedom were 
adjusted from 1598 to 159.  
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Model 1: Logistic Regression Predicting Dementia/CIND at Age > 55 (including Sex and Race) 
Model 
 Predictor  




CurrentAge 0.16 0.02 1.18 [1.12, 1.23] 48.85** .000 
MDD 0.59 0.15 1.80 [1.34, 2.42] 15.36** .000 
PTSD 0.48 0.15 1.62 [1.21, 2.16] 10.63** .001 
Sex -0.28 0.12 0.76 [0.60, 0.96]   5.25* .022 
Race -0.17 0.12 0.84 [0.67, 1.05]   2.26 .133 
         
1b 
CurrentAge 0.16 0.02 1.18 [1.12, 1.23] 47.82** .000 
MDD 0.27 0.24 1.32 [0.83, 2.09]   1.36 .244 
PTSD 0.41 0.22 1.51 [0.98, 2.35]   3.43 .064 
Sex -0.36 0.24 0.70 [0.44, 1.11]   2.28 .131 
Race -0.42 0.24 0.66 [0.41, 1.04]   3.20 .074 
Sex*MDD 0.14 0.30 1.15 [0.64, 2.08]   0.21 .644 
Sex*PTSD 0.08 0.31 1.08 [0.59, 1.96]   0.06 .805 
Race*MDD 0.57 0.30 1.77 [0.98, 3.20]   3.59 .058 
Race*PTSD 0.09 0.30 1.10 [0.61, 1.98]   0.10 .756 
         
1c 
CurrentAge 0.16 0.02 1.18 [1.12, 1.23] 49.58** .000 
MDD 0.36 0.19 1.43 [0.99, 2.06]   3.60 .058 
PTSD 0.48 0.15 1.62 [1.21, 2.16] 10.69** .001 
Sex -0.28 0.12 0.76 [0.60, 0.96]   5.26* .022 
Race -0.36 0.15 0.70 [0.52, 0.93]   6.18* .013 
Race*MDD 0.52 0.24 1.67 [1.05, 2.67]   4.66* .031 
Note. N = 4,800. CI = confidence interval for odds ratio (OR). MDD and PTSD coded as “0” (no 
history of MDD/PTSD at age < 55) or “1” (with a history of MDD/PTSD at age < 55). Sex 
included Female (coded as “1”) and Male (coded as “0”). Race included Black (coded as “1”) 
and White (coded as “0”). Model 1c variables were entered using Backward LR method. 





Model 2: Logistic Regression Predicting Dementia/CIND at Age > 55 (including Sex) 
Model 
 Predictor  




CurrentAge .165 .023 1.18 [1.13, 1.23] 51.71** .000 
MDD .592 .150 1.81 [1.35, 2.43] 15.57** .000 
PTSD .479 .147 1.61 [1.21, 2.15] 10.57** .001 
Sex -.271 .120 0.76 [0.60, 0.97]   5.10* .024 
         
2b 
CurrentAge .164 .023 1.18 [1.13, 1.23] 50.03** .000 
MDD .533 .195 1.71 [1.16, 2.50]   7.45** .006 
PTSD .446 .187 1.56 [1.08, 2.26]   5.67* .017 
Sex -.355 .236 0.70 [0.44, 1.11]   2.26 .133 
Sex*MDD .140 .303 1.15 [0.64, 2.08]   0.22 .642 
Sex*PTSD .081 .305 1.09 [0.60, 1.97]   0.07 .790 
2duration 
CurrentAge .151 .023 1.16 [1.11, 1.22] 43.66** .000 
MDDduration .041 .010 1.04 [1.02, 1.06] 15.57** .000 
PTSDduration .032 .010 1.03 [1.01, 1.05] 10.45** .001 
Sex -.270 .120 0.76 [0.60, 0.97]   5.06* .024 
Note. N = 4,800. CI = confidence interval for odds ratio (OR). MDD and PTSD coded as “0” (no 
history of MDD/PTSD at age < 55) or “1” (with a history of MDD/PTSD at age < 55). Sex 
included Female (coded as “1”) and Male (coded as “0”). In Model 2b, interactions between Sex 
and MDD and PTSD were added. A third step was taken using the Backward LR method, which 
yielded the same variables as Model 2a, thus results were not included in this table. The same 
methods were used to examine MDDduration and PTSDduration, and the steps in Model 2duration 
yielded similar results as the steps in Model 2. MDDduration and PTSDduration = # of years 
since the first MDD/PTSD diagnosis, respectively.  





Model 3: Logistic Regression Predicting Dementia/CIND at Age > 55 (including Race) 
Model 
 Predictor  




CurrentAge .174 .022 1.19 [1.14, 1.24] 60.75** .000 
MDD .594 .150 1.81 [1.35, 2.43] 15.70** .000 
PTSD .492 .147 1.64 [1.23, 2.18] 11.19** .001 
Race -.167 .115 0.85 [0.68, 1.06]   2.11 .147 
         
3b 
CurrentAge .175 .022 1.19 [1.14, 1.25] 61.39** .000 
MDD .338 .200 1.40 [0.95, 2.08]   2.87 .091 
PTSD .456 .190 1.58 [1.09, 2.29]   5.73* .017 
Race -.415 .236 0.66 [0.43, 1.05]   3.10 .078 
Race*MDD .572 .302 1.77 [0.98, 3.20]   3.60 .058 
Race*PTSD .094 .300 1.10 [0.61, 1.98]   0.10 .754 
         
3c 
CurrentAge .175 .022 1.19 [1.14, 1.25] 61.45** .000 
MDD .361 .187 1.44 [1.00, 2.07]   3.73 .053 
PTSD .494 .147 1.64 [1.23, 2.19] 11.25** .001 
Race -.358 .146 0.70 [0.53, .093]   5.98* .015 
Race*MDD .515 .239 1.67 [1.05, 2.67]   4.65* .031 
3duration 
CurrentAge .162 .022 1.18 [1.13, 1.23] 52.06** .000 
MDDduration .024 .013 1.02 [1.00, 1.05]   3.40 .065 
PTSDduration .034 .010 1.03 [1.01, 1.06] 11.25** .001 
Race -.356 .145 0.70 [0.53, 0.93]   6.01* .014 
Race*MDDduration .038 .017 1.04 [1.01, 1.07]   5.00* .025 
Note. N = 4,800. CI = confidence interval for odds ratio (OR). MDD and PTSD coded as “0” (no 
history of MDD/PTSD at age < 55) or “1” (with a history of MDD/PTSD at age < 55). Race 
included Black (coded as “1”) and White (coded as “0”). In Model 3b, interactions between Race 
and MDD and PTSD were added. In Model 3c, all the variables from 3b were entered using 
Backward LR method, and Model 3c included all the variables from the final step of the 
backward LR logistic regression analysis. The same methods were used to examine 
MDDduration and PTSDduration, and the steps in Model 3duration yielded similar results as the 
steps in Model 3. MDDduration and PTSDduration = # of years since the first MDD/PTSD 
diagnosis, respectively. 




Observed and Predicted Frequencies for Dementia/CIND by Logistic Regression Models 
Model Observed 
Predicted Dementia 
% Correct No Yes 
1c 
DEM/CIND No 2,719 1,745 60.9 
 Yes 139 197 58.6 
Overall %     60.8 
2a 
DEM/CIND No 2,730 1,734 61.2 
 Yes 132 204 60.7 
Overall %     61.1 
3c 
DEM/CIND No 2,752 1,712 61.6 
 Yes 127 209 62.2 
Overall %     61.7 
Note. N = 4,800. Classification cut off = .07. Model 1c variables = CurrentAge, MDD, PTSD, 
Sex, Race, and Race*MDD. Model 2a variables = CurrentAge, MDD, PTSD, and Sex. Model 3c 















with multiple race 




•Created 3 cohort 
tables with subjects 
meeting diagnostic 
criteria
Cohort 1 (MDD) = 
115,245
Removed 
60,169  with 
dementia/CIND 
before age 56
Final Cohort 1 = 
55,076
Created 4 group tables 
based on demographic 
criteria:
C1G1 Black/Female = 
1,328
C1G2 White/Female = 
4,544
C1G3 Black/Male = 
10,447











Final Cohort 2 = 
84,853
Created 4 group tables 






C2G7 Black/Male = 
18,354











Final Cohort 3 = 
620,403
Created 4 group tables 






C3G11 Black/Male = 
134,045
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Figure 5. Receiver Operating Characteristic (ROC) Curve for Risk of Dementia/CIND 
(diagnosed at age > 55) based on Logistic Regression Models 1c, 2a, and 3c. Model 1c (Table 7) 
variables = CurrentAge, MDD, PTSD, Sex, Race, and Race*MDD. Model 2a (Table 8) variables 
= CurrentAge, MDD, PTSD, and Sex. Model 3c (Table 9) variables = CurrentAge, MDD, PTSD, 





ICD-9 Dementia and Cognitive Impairment Not Demented (CIND) Codes and Descriptions 
290.00 Senile dementia, uncomplicated 
290.10 Presenile dementia, uncomplicated 
290.11 Presenile dementia, with delirium 
290.12 Presenile dementia, with delusional 
features 
290.13 Presenile dementia, with depressive 
features 
290.20 Senile dementia, with delusional 
features 
290.21 Senile dementia, with depressive 
features 
290.30 Senile dementia, with delirium 
290.40 Vascular dementia, uncomplicated 
290.41 Vascular dementia, with delirium 
290.42 Vascular dementia, with delusions 
290.43 Vascular dementia, with depressed 
mood 
291.10 Wernicke-Korsakoff syndrome 
(alcoholic) 
291.20 Alcohol-induced persisting dementia 
292.82 Drug-induced persisting dementia 
294.00 Persistent mental disorders due to 
conditions classified elsewhere 
294.10 Dementia in conditions classified 
elsewhere, without behavioral 
disturbance 
294.11 Dementia in conditions classified 
elsewhere, with behavioral 
disturbance 
294.20 Dementia, unspecified, without 
behavioral disturbance 
294.21 Dementia, unspecified, with 
behavioral disturbance 
294.80 Persistent Mental Disorders Due to 
Conditions Classified Elsewhere, 
Other; Amnestic Disorder NOS, 
Dementia NOS 
294.90 Other specified mental disorders due 
to known physiological condition; 
Cognitive Disorder NOS 
310.10 Senility with mental changes of 
nonpsychotic severity 
310.80 Mild memory disturbance 
310.89 Mild memory disturbance, not 
amounting to dementia, associated 
with senile brain disease (other 
specified nonpsychotic mental 
disorders following organic brain 
damage) 
323.90 Leukoencephalopathies 
331.00 Alzheimer's disease 
331.10 Frontotemporal dementia 
331.11 Pick's Disease 
331.19 Other frontotemporal dementia 
331.20 Senile degeneration of brain 
331.80 Other cerebral degeneration 
331.82 Dementia with Lewy bodies 
331.83 Mild cognitive impairment, so stated 
331.89 Other cerebral degeneration 
331.90 Cerebral degeneration unspecified 
388.00 Degenerative and vascular disorders, 
unspecified 
437.00 Cerebral atherosclerosis 
437.10 Other generalized ischemic 
cerebrovascular disease 
437.20 Hypertensive encephalopathy 
437.80 Other ill-defined cerebrovascular 
disease 
437.90 Unspecified cerebrovascular disease 
438.00 Late effect of cerebrovascular 
disease, cognitive deficits  
780.83 Memory loss 
797.00 Senility without mention of 
psychosis 
799.55 Frontal lobe and executive function 
deficit 





ICD-9 Major Depressive Disorder (MDD) and Posttraumatic Stress Disorder (PTSD) 
Codes and Descriptions
 
296.2 Major depressive affective disorder, single episode, unspecified degree 
296.21 Major depressive affective disorder, single episode, mild degree 
296.22 Major depressive affective disorder, single episode, moderate degree 
296.23 Major depressive affective disorder, single episode, severe degree, without psychotic 
behavior 
296.24 Major depressive affective disorder, single episode, severe degree, specified as with 
psychotic behavior 
296.25 Major depressive affective disorder, single episode, in partial or unspecified remission 
296.26 Major depressive affective disorder, single episode, in full remission 
296.3 Major depressive affective disorder, recurrent episode, unspecified degree 
296.31 Major depressive affective disorder, recurrent episode, mild degree 
296.32 Major depressive affective disorder, recurrent episode, moderate degree 
296.33 Major depressive affective disorder, recurrent episode, severe degree without psychotic 
behavior 
296.34 Major depressive affective disorder, recurrent episode, severe degree, specified as with 
psychotic behavior 
296.35 Major depressive affective disorder, recurrent episode, in partial or unspecified remission 
296.36 Major depressive affective disorder, recurrent episode, in full remission 
 
309.81 Post-traumatic stress disorder, acute 
309.81 Posttraumatic stress disorder, brief 
309.81 Posttraumatic stress disorder, chronic 
 
 
